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Long before the isolation and crystallization of vitamin C
the deficiency disease caused by its lack was known. Scurvy
was the scourge of sea-faring men ever since they relied on
stored food during long voyages. The disease was "by no
means restricted to sailors and it tookoheavy toll of human
lives in time of war and famine when fresh food was scarce.
People like Hawkins ( 1 ) and Lind ( 2 ) rightly appreciated
the usefulness of lemon juice and fresh vegetables in prevent¬
ing and curing this malady. In the early twentieth century
while the concept of " acoessory food factors n to be termed
later "Yitamine " by Punk ( 3,4 ) was in the air, Hoist ( 5 )
was studying the etiology of ship-beri-beri by keeping
chickens and pigeons on bread, groats, and unpeeled grains.
He thought that convincing evidence regarding the etiology of
ship-beri-beri could not be obtained from experiments on
poultry so he experimented with mammalia. Hoist and Frolich
( 6 ) observed that when guinea pigs were kept on a similar
diet they developed a disease similar to scurvy in man. They
considered the disease to result from the lack of a " special
nutrient n. The disease v;as curable by supplementing the diet
with fresh cabbage, potato, apple, etc. The work of the afore¬
said authors was of great significance not only because of its
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conformity with the vitamin hypothesis hut also because of the
fact that fox the first time an experimental animal which re¬
quired ascorbic acid had been found, This discovery was of
great assistance to the workers of later date, because, during
the isolation and the determination of the chemical nature of
vitamin C, biological assays using the guinea pig had necess¬
arily to be done frequently.
Twenty-six years ago Szent-Gyorgyi ( 7a ) while working in
Cambridge isolated a reducing substance from adrenal cortex,
cabbage, and orange. The reducing substance was a highly act¬
ive carbohydrate derivative, isomeric with glyouronic acid;
and after losing water formed a reversible crystalline lactone
anhydride with a formula CgHgOg . The exact constitution was
not known, but he proposed the name n hexuronic acid ", Szent-
Gyorgyi at that time did not realize the identity of his sub¬
stance with vitamin C. Five years later King and Waugh ( 8 )
isolated the antiscorbutic vitamin in crystalline form and
identified their substance with that of Szent-Gyorgyi's
" hexuronic acid n. Later in the same year Svirbely and Szent-
Gyorgyi (9,1° ) definitely established the antiscorbutic pot¬
ency of M hexuronic acid w and the identity of the latter sub¬
stance with vitamin C. Szent-Gyorgyi and Haworth ( 11 ) propos¬
ed the name ascorbic acid ( AsA )• Karris and Ray ( 12 )
followed by other workers confirmed the work of King and Waugh,
Svirbely and Szent-Gyorgyi, The structural formula and chemical
properties have been worked out by Hirst and his colleagues ( 13»
-3-
14,15 ). Other Y/orkers also contributed to the solution of this
important problem# Synthesis was effected by Heichstein and his
associates ( 16,17 ).
Hirst and his coworkers ( 13,14 )» Borsook, Davenport, Jeffreys,
and Warner ( 21 ) demonstrated that, in vitro, ascorbic acid is
converted to dehydroascorbic acid, diketogulonic acid, threonic







































The immediate reversible oxidation product of ascorbic acid is
dehydroascorbic acid ( bha )* Numerous workers ( 18-22 ) have
reported that dehydrogenated ascorbic acid is reduced to ascorbic
acid in vivo and is completely utilized as such, i#e. dehydro¬
ascorbic acid has the same antiscorbutic potency as ascorbic
acid# There are certain findings, which lend credence to the
view that glutathione is responsible for this reduction, and
will be discussed later# However, dehydroascorbic acid suffers
an irreversible non-oxidative change, both in vitro and in vivo,
and is converted to diketogulonic acid ( dka ) ( 13,14*21,23,24 ).
»
Hirst et al« ( 14 ) have shown that the lactone ring once broken
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is not reconstructed easily in vitro, except "by drastic treat¬
ment with HI. In vivo there is no such mechanism for the re¬
construction of the lactone ring, therefore, DKA is not anti-
scorbutically potent ( 21,23 ). Penney and Zilva ( 23 ) who
have extensively studied the in vitro and in vivo conversion
of DHA to DKA suggested that in the "body ascorbic acid is
probably destroyed as follows:
In the same year Bosenfeld ( 26 ) published a paper in which he
questioned the existence of DKA as a normal metabolic intermed¬
iate in the catabolism of ascorbic acid. According to the
latter author the reversible oxidation product of ascorbic acid
undergoes an intramolecular stabilization resulting in, probably
the formation of enollzed DKA lactone? catalytic amount of
phosphate induces hydrolytic splitting of the 6-carbon chain
of the latter compound and as a result of which oxalic acid is
formed quantitatively and possibly oxalyl threose. (See below).
AsA DHA ■» DKA
0=0
0=0








Hecently Damron, Monier, and Roe ( 24 ) suggested that ascorbic
acid is not converted to JEA or DKA in the course of its normal
metabolic destruction, although, when large doses of AsA or DHA
are administered then these compounds are destroyed via the
pathway proposed by Penney and Zilva ( 23 )• At the present
moment, the significance of DKA as a metabolic intermediate in
the normal eatabolism of AsA is polemical, however, the former
compound as a chemical entity and the product of irreversible
biological transformation has gained acceptance in the litera¬
ture ( 13-15, 21,23,27 ),
Although Sosenfeld ( 26 ) suggested from the results of his in
vitro experiments that oxalate is the end-product of ascorbic
acid metabolism, it was not until very recently that convincing
experimental proof for such conversion in vivo has been furnish¬
ed. Burns, Burch, and King ( 25 ) administered ascorbic acid
labeled with to guinea pigs and measured the amount of
eliminated in respiratory C02 and in urine, Phey found that
in 24 hrs. on the average 28$ of the C1^ appeared in the respir¬
atory CO2 and 5$ in the urine; oiit of the latter 30-60$ was
present in the urinary oxalate. The above experiment is strong¬
ly suggestive that the conversion of AsA to C02 is a main route
of its metabolism and that oxalate is an end-product of ascorbic
acid metabolism.
Very recently King and his group ( 28-31 ) working with gluoose~14C
have shown that B-gluoose is almost certainly a precursor of
ascorbic acid in animals, and since the yield of labeled ascorbic
acid from glucuronic acid is high, it indicates that glucuron¬
ic acid is an intermediate in the normal route of ascorbic acid
formation. Isherwood, Chen, and Mapson ( 32 ) have provided
evidence which suggests that a similar conversion takes place in
plants.
The ease with which the reduced form of the vitamin reacts with
numerous.oxygen carriers and undergoes reversible oxidation-
reduction that biochemists have been trying to associate it
with various enzyme systems taking part in cellular respiration.
Unfortunately however, to date, most of the attempts to link
ascorbic acid with any definite enzyme system have ended in
failure.
The known facts about ascorbic acid have been summarized
recently by Harris ( 33 ) and are cited belows
(1) In ascorbic acid deficiency there is functional derange¬
ment of the formative cells of the body ( odontoblasts,
ameloblaets, oementoblasts, osteoblasts ) and they stop produc¬
ing normal type of new tissues ( dentine, enamel, cement, bone ).
Hormal production of collagen is also hampered in ascorbic acid
deficiency.
(2) It has been proved almost certainly that ascorbic acid
takes part in two well defined chemical reactions ( a 5 conversion
of folic acid to folinic acid, ( b ) the metabolism of tyrosine
and related amino-acids.
A new aspect of chemical role of ascorbic acid has been suggested
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quite recently by Becker, Burch, Solomon, Venkitasubramanian,
and King ( 34 ). lEhey have shown that cholesterol metabolism
is deranged in scorbutic guinea pigs.
Glutathione
She discovery of glutathione as a chemical substance dates back
further than that of the ascorbic acid. In 1833 de Bey Pailhade
( 35,36 ) showed that aqueous extracts of yeast have the power
to reduce sulfur to hydrogen sulfide, later he observed that
many animal tissues possessed the same property, de Bey
Pailhade called the substance responsible for this effect
" Philothion ". However, it was forgotten for a long time,
until Hopkins ( 37 ) isolated this substance from yeast, muscle,
liver etc. He thought the substance to be a dipeptide contain¬
ing glutamic acid and cysteine, and suggested the present name
to maintain a link with de Bey Pailhade's " Philothion ".
Hopkins suggested that glutathione (GSH ) plays a role in the
oxidation-reduction system in animals. Stewart and Tunnicliffe
( 38 ) synthesized gltitaminyl-cysteine and regarded it as
identical with Hopkins's material. Hunter and Eagles ( 39 )
prepared glutathione according to Hopkinss method and they could
not corroborate their finding with that of Stewart and Tunni-
eliffe; their analytical results indicated that glutathione
was not a simple dipeptide of cysteine and glutamic acid and
that there was a third amino-acid present, possibly, serine in
ester linkage; although, they had no experimental proof to
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support their contention, Hopkins ( 40 ) reinvestigated the
problem and found that, in addition to glutamic acid and
cysteine, glycine was also present, Through the work of
Hopkins ( 40 ) Pirie and Pinhey (41 ), Kendall, MacKenzie,
and Mason ( 42 ), Harrington and lead ( 43 ) the structure of







The universal distribution of glutathione has been recognized.
It is present almost exclusively in the intracellular fluid,
Rapkine ( 44-46 ) first formulated the role of glutathione in
coll division and cell growth. He showed that in sea urchin
eggs the concentration of glutathione falls soon after
fertilization and that subsequently there is a considerable
increase about 45 minutes after fertilization. However, the
mechanism of action of thiols in cell division or growth is
not known as yet.
CHgSH
CH2 COOH
Lohmann ( 47 ) showed for the first time that glutathione acts
as a coenzyme in the glyoxalase system and the activity of
which is dependent upon the amount of glutathione present.
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Eeeently Eacker ( 4B ) has worked out the details of the mechan¬
ism of this action of glutathione, ho other enzyme system has
teen discovered where glutathione acts as a coenzyme. Hopkins
and Morgan ( 49 ) found wide distribution of glyoxalase in
living organisms ( vertebrates, invertebrates, and higher plants ).
The metabolic significance of glutathione-glyoxalase system,
however, is not clear at the present time,
»
Glutathione plays a protective role in animal organisms. There
are a number of enzymes which need the presence of -SE groups
in their protein moiety for activity, a number of these enzymes
are connected with the oxidation of aminoacids, carbohydrates,
and fats. If the -SH groups of these enzymes are attacked by
substances which destroy the -SH groups, glutathione restores
the sulfhydryl groups either by withdrawing the destroying
agent or reducing the -SH groups if the latter are oxidized.
Thus glutathione is a protective or reactivating agent ( 50 ).
Within this protective role, probably, falls the action of
glutathione against the induction of alloxan and dehydroascorbic
acid diabetes ( 51 )• Soluble thiols of which glutathione is
perhaps the most representative example has been suggested as
responsible for the maintenance of the n steady state and
the regulation of the energetic processes of the cells ( 50 ).
numerous other papers have been published on the possible
biological function of glutathione but, to date, nothing has
been definitely established.
The metabolism of glutathione has been studied quite extensively
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in recent years with, the aid of isotopic components of the
tripeptide. Waelseh and Eittenberg ( 52,53 ) demonstrated the
rapid incorporation of isotopic glycine and glutamic acid into
the glutathione of liver and intestine of rabbits and rats.
The rate of incorporation of the two aminoacids into gluta¬
thione is far quicker than into the proteins of the same organs.
According to the aforesaid authors the half-lifetime of gluta¬
thione in vivo is 2-4 hours. Other observers have since con¬
firmed the rapid turnover of glutathione both in vivo and in
vitro ( 54*55 ). Bloch and his associates ( 54*56-58 ) have
reported the enzymic synthesis of labeled glutathione from
C1^glycine and N -glutamic acid in liver slices and homogen-
ates. Their studies strongly indicate that adenosinetriphos-
phate ( ATP ) participates in the synthesis of glutathione.
The enzymic splitting of glutathione into its component amino¬
acids has been reported by a number of workers ( 59-63 ).
Recently Olson and Binkley ( 63 ) have separated the enzyme
responsible for the hydrolytic cleavage of gamma-glutamyl
linkage from the one responsible for the hydrolysis of
cy ste iny lglyc ine.
In a recent review Barron ( 50 ) has concluded that glutathione
may be oxidized in the cells by cupric ions, cytochrome
c-cytochrome oxidase, and HgOg-peroxidase. Ames and Elvehjem
( 64,65 ) purported that cytochrome e is mainly responsible for
the oxidation of glutathione; in the absence of the aforesaid
enzyme the oxidation of glutathione is effected, possibly, by
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a coenzyme I-linked enzyme system. The influence of coenzyme I
on the oxidation of glutathione, in the presence of cytochrome
e, is only secondary in nature. They ohserved that ascorbic
acid increased the rate of oxidation of glutathione by tissue
homogenates both in the presence and in the absence of cyto¬
chrome c. However, since on further addition of ascorbic acid
the oxidation rate of glutathione did not increase, they re¬
garded the stimulating action of ascorbic acid on the rate of
oxidation of glutathione as catalytic. Conn and Vennesland
( 66 ) have demonstrated the presence of an enzyme in wheat
gem which catalyzes the reduction of oxidized glutathione
( GSSG ) in the presence of triphosphopyridine nucleotide
( TPN ). lapson and Goddard ( 67 ) have also expounded the
existence of such an enzyme in a number of plant tissues.
Hall and Lehninger ( 68 ) have shown that a TPIT-linked gluta¬
thione reductase exists in kidney, liver, spleen, heart musole,
brain, skeletal muscle, blood cells, and blood serum. The
specific activity of the enzyme decreases in the order listed
above. According to Hall and lehninger the aforesaid enzyme
shows specificity for both GSSG and TPIHg and effects the
reduction of the former as follows:
TBIHg + GSSG * 2GSH + TPN
At the present moment there is no unanimity of opinion regard¬
ing the state of glutathione in blood and tissues, although the
foregoing literatures show that there exist, in vivo, mechanisms
for the oxidation and reduction of glutathione.
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Glutathione and Ascorbic Acid
Glutathione and ascorbic acid have "been closely associated
in the minds of the biochemists because of the ubiquitous
distribution of both, the close similarity of their
properties with respect to the ease with which both are
oxidized and reduced, and the tremendous concentration of
both in embryonic tissues where synthetic processes occur
at a great speed etc. Szent-Gyorgyi ( 7a ) in the earliest
communication on " hexuronic acid " observed that oxidized
n hexuronic acid " is reduced by animal tissues and con¬
current with the reduction of the former a progressive
diminution of the nitroprusside reaction takes place. He
concluded that oxidized " hexuronic acid n is reduced by
glutathione, fixed thiol groups, and other unidentified
factors. In a later publication Szent-Gyorgyi ( 7b ) pur¬
ported the presence of an enzyme " hexoxidase n in plant
tissues which catalyzed the oxidation of " hexuronic acid w.
He reported that the former, in the absence of the latter,
is without any effect on glutathione. On the other hand,
if rt hexuronic acid " is present then glutathione is vicar¬
iously oxidized. Hopkins and Morgan ( 69 ) amplified the
idea and demonstrated that, when ascorbic acid and gluta¬
thione are present together in the presence of ascorbic acid
oxidase, ascorbic acid is completely protected from oxidation
by this specific oxidase, and glutathione is directly oxidized.
In the above system when reduced glutathione disappears almost
-In¬
completely then ascorbic acid is oxidized* They explained the
above protective action of glutathione on the basis of active
hydrogen transfer from two molecules of glutathione to each
activated molecule of ascorbic acid, and thus keeping the
latter in the reduced form* Their observations also include
such facts that glutathione protects ascorbic acid from
catalytic oxidation by copper, and that dehydroascorbic acid
is reduced by glutathione. According to the aforesaid authors
glutathione inhibits copper induced oxidation of ascorbic acid
by forming a compound with copper and thereby preventing the
effective contact between copper and ascorbic acid. In the
above paper it was further suggested that glutathione in very
high concentrations might protect ascorbic acid from oxidation
in the liver tissues. Kertesz ( 97 ) could not confirm the
work of the above authors. Crook and Hopkins ( 71 ) repeated
and extended the work of Hopkins and Morgan ( 69 ) and fully
confirmed the original work. At a later date Crook ( 93 ),
Crook and Morgan ( 72 ) further substantiated the original
claim by partial separation of ascorbic acid reductase from
oxidase and demonstrated the fact that the former was responsible
for catalyzing the reduction of dehydroascorbic acid by gluta¬
thione .
Roe and Barnum ( 73 ) observed that whole blood, blood plasma,
and washed red cells of different species when incubated with
dehydrogenated ascorbic acid reduced the latter to ascorbic
acid. On the other hand, Ra-fluoride treated or heated plasma
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and tungstic acid filtrate of whole blood lost the power to
reduce dehydroascorbic acid to ascorbic acid, They concluded
that dehydroascorbie acid is reduced by an enzyme present in
the blood of humans, guinea pigs, and rats. Borsook, Davenport
Jeffreys, and Warner ( 21 ) suggested on the basis of their
in vitro experimental findings that glutathione is perhaps
mainly responsible for the reduction of dehydroascorbie acid
in some animal tissues, Schultze, Stotz, and King ( 74 )
could not confirm the work of Roe and Barnum ( 73 ) and they
concluded that dehydroascorbic acid is reduced by a reversible
reaction with glutathione and fixed -SH compounds of the
tissues. Barron ( 50 ) believes that the reduction of dehydro
ascorbic acid by glutathione as suggested by Borsook et al,
does not take place under physiological conditions. Recently
in human subjects Prunty and Vass ( 70 ) have shown statistic¬
ally significant negative correlation between the values of
plasma ascorbic acid and reduced glutathione levels in the red
cells after the administration of large doses of ascorbic acid
Furthermore, they have pointed out that a fall in the reduced
glutathione of blood is accompanied by a rise in the oxidized
glutathione in the above cases.
To date, no enzyme system which catalyzes the oxidation-
reduetion of ascorbie acid, such as has been found in plants,
has been definitely established in animal tissues. Although,
glutathione has been suggested as the principal reducing agent
for the reduction of dehydroascorbic acid in animal tissues,
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the ease is far from "being decisively proved.
Oxidized aseorMc acid and glutathione have "been related in an
entirely different "biochemical role in recent years, i.e. in
relation to the production of experimental diabetes and its
prevention ( 75 ).
She gradual unfolding of our knowledge about ascorbic acid and
glutathione is fascinating and it has been very briefly summar¬
ized in this review. In the subsequent sections literatures,
which have a direct bearing on the problems studied, will be
discussed more fully.
PAKE I
INVESglGAPIONS 01? SEE POSSIBLE EXISTENCE
OP 33EIIYDROASCOEBIC ACID IN BABBIT PLASMA
AND ITS ALTERATION BY INJECTION OP ALLOXAN
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PAB2 I
Invcotigat ions^on ,the. Possible Dxiotenoc of XteMdroascorbic
Acid in Babbit Plasma .and its Alteration by Infection of
Since the discovery by Durni, Sheehaa, and Ucletehie ( 76 ) that
alloxan causes a selective necrotic degeneration of the beta-
eello in the isle ts of langerhans of me pancreas, numerous papers
have teen published on the possible role of alloxan in the
etiology of human diabetes* So date, it has not been proved
decisively that alloxan exists normally in the body (77 )» or
that it appears in significant amount under abnormal metabolic
conditions, notwithstanding that there are some suggestions to
that effect { 73 )» nevertheless, alloxan has been a very
helpful tool to the biologists as a means of producing experi¬
mental diabetes and for following many of the complicated
metabolic derangements associated with that condition* Very
recently Patterson ( 79,30 ) has shown that the intravenous
injection of dehydroascorbic acid into rats results in the
production of diabetes. He pointed out the structural resem¬





Prineiotto ( 31 ) lias extended Patterson1 s observation by
making rabbits diabetic with dehydroascorbie acid. Unlike
alloxan, ascorbic acid is definitely known to be a normal
constituent of the body tissues and one of the chemical
properties of ascorbic acid is that it is fairly easily
oxidised reversibly to dehydroaseorbic acid ( 13-15 )•
However, till the recent publication of the paper by
Stewart, Horn, and Eobson ( 83 ), ascorbic acid has been
generally thought to exist mainly in the reduced form in the
body ( 21,34,35 ). Stewart et al. reinvestigated the problem
and suggested that dehydroascorbic acid exists in the human
plasma and that diketogulonic acid does not exist. They
further found confirmatory evidences in their experiments
f
with ACIH, Cortisone, and Salicylate administration which
altered the ratio of ascorbic acid to dehydroascorbic acid
C 36 ).
It has been suggested that alloxan combines with or oxidizes
reduced glutathione ( 82 ). If, reduced glutathione is res¬
ponsible for maintaining ascorbic acid in the reduced form
in animals, as has been suggested in plants by Hopkins and
Morgan ( 69 ), then, there is a possibility that alloxan by
combining with or oxidizing reduced glutathione may indirectly
cause the formation of dehydroascorbieacid.
The immediate purpose of the work in this section is, therefore,
to investigate whether dehydroascorbic acid exists in the plasma
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of other animals besides human and whether the diabetogenic
action of alloxan is due to or associated with the formation
of dehydroascorblc acid.
EXPERIMENTAL
Rabbits purchased from recognised dealers and subsequently
inbred in this laboratory were used throughout the work of
this thesis. During this experiment they were maintained
on a daily ration of bran, oats, hay, and water ad libitum.
In a few preliminary experiments it was observed that the
ascorbic acid level in the plasma of such animals was very
low. Since the purpose of the experiment was to observe
whether dehydroascorbic acid wa3 present in significant
amount in the plasma of rabbits, and whether the concen¬
tration of the aforesaid substance altered by alloxan in¬
jection, the vitamin C concentration in the plasma of the
experimental animals was raised by supplementing the diet
with cabbage. In this way the estimation of ascorbic acid
in the plasma was facilitated and experimental errors
minimised.
Technique of Blood Collection;
The apex beat of the heart was palpated and as close to it
as possible a hypodermic needle was pushed into the thoracic
cavity towards the throb at an angle of 45° from the long
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axis of the rabbit's body till the blood came out in spurts,
which indicates that the left ventricle is pierced. If the
right ventricle is pierced then the flow is much slower and
when the auricles are punctured the flow is of even type.
The outflowing blood was collected in a heparinized syringe.
In one bleeding approximately 20-40 ml. of blood were collect¬
ed. The same animal was used again sometimes, provided it
received no other form of treatment and at least seven weeks
elapsed between two bleedings.
Blood obtained by the above procedure was centrifuged for
10-15 minutes; ascorbic acid and total ascorbic acid deter¬
minations were made in the same sample of non-hemolyzed plasma.
Methods
Ascorbic acid was estimated by the modified indophenol method
of Stewart, Horn, and Robson ( 83 ). Total ascorbic acid was
estimated by the method of Hoe and Kuether ( 87 ), and Mapson
and Ingram ( 88 ).
Eecoveries of the pure . substance added to plasma by the
indophenol method ranged from 95-100$ and by the Roe and
Kuether * s phenyHydrazine method from 98-101$. When 12
determinations were made by the indophenol and phenyHydrazine
methods on the same sample of plasma containing no ascorbic aeid
and to which 1 mg.$of ascorbic acid was added the recoveries
were as follows;
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Methods lean Range Standard
Deviation
Indophenol 0.954 mg. 0.925-1.0 mg. ±0.0297
per 100 ml. per 100 ml.
Pheny lbydrazine 0.981 mg. 0.95-1.02 mg. ±0.034
per 100 ml. per 100 ml.
The principles of tiie above methods may be recalled briefly:
A. Indophenol method:
She reduction of the dye 2:6- dichlorophenolindophenol by
ascorbic acid is complete within 30 seconds and other reducing
substances normally present in the plasma do not react with
indophenol within that short time and under the specified
conditions. Hence the indophenol method measures the amount
of reduced ascorbic acid present in the placna.
B. Roe and Kuether's method for total ascorbic acid:
All the reduced ascorbic acid is converted by activated char¬
coal to dehydroascorbic acid. When the latter substance is
incubated with 2:4-dinitrophenylhydrasine it is converted to
dilcetogulonic acid ( 23,89 ) and couples with 2:4-dinitro-
phenyHydrazine. The resulting osazones are dehydrated with
85$ H2S0^ and a red color is produced which is measured photo¬
metrically. It should be noted that any preformed dehydroascorbic
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acid and diketogulonio acid also react with phenylhydrazine
to form osazones. therefore, this method measures ascorbic
acid plus dehydroaseorbic acid and diketogulonic acid.
G. Mapson and Ingram's method for total ascorbic acids
Esch, coli reduces dehydroascorbic acid to ascorbic acid under
anaerobic conditions, at pH 6.2 and 35°. Hence any increase
in indophenol reducing power of plasma after Esch. coli treat¬
ment is believed to be due to the reduction of dehydroascorbic
acid to ascorbic acid.
BESULTS AO DISCUSSION
The results obtained by the indophenol and phenylhydrazine
methods are spoken of as indophenol and phenylhydrazine values
in the course of this discussion. In the fables the column
TEA ? shows the difference between the phenylhydrazine and
indophenol values; a plus sign is used when the former is
higher than the corresponding value of the latter and a minus
sign indicates the reverse.
The analyses for ascorbic acid and total ascorbic acid in
the plasma of rabbits whose diets were supplemented with
cabbage are presented in Table la. It can be seen that
in most cases the phenylhydrazine values are lower than
the indophenol values and that the differences are often
greater than would be expected as a result of experimental
error. These results are quite different from those obtained
SABLE la
Concentrations of Ascorbic Acid and Total Ascorbic Acid in




Very high cabbage Cabbage ad libitum every day of the week







































9 1500 0.95 -0.125 0.825
10 2100 0.925 -0.175 0.75















5 164-0 1.22 -0.17 1.05
6 2150 1.82 -0.02 1.8
19 0.95 +0.02 0.97
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in the human plasma by Stewart, Horn, and Robson ( 83 ). It
seemed likely that some substance from cabbage, which when
assimilated and circulated in the plasma of these rabbits,
was responsible for giving such falsely high indophenol
values# Long, Miles, and Perry ( 90 ) suggested that cabbage
probably contains a factor of -SH nature. It was argued,
therefore, that, if cabbage contains a factor of sulfhydryl
nature the latter substance would react with indophenol but
not with phenylhydrazine, and as a result of this a falsely
high indophenol value would be obtained and the true differ¬
ence, if any, between the phenylhydraaine value and the indo¬
phenol value would be masked. On the other hand, if ascorbic
acid and total ascorbic acid were measured by the same method,
then, interference would be present in both cases and if
dehydroascorbic acid existed then the total ascorbic acid
value would be higher than the ascorbic acid value. It was,
therefore, decided to reduce the dehydroascorbic acid by a
suitable reducing agent and to estimate the total ascorbic
acid by the indophenol method. The first choice of reducing
agent was HgS as originally applied by Stewart et al. ( 83 )•
In the course of this investigation it was found that when
dehydroascorbic"5" acid was added to plasma to give a concen¬
tration of 0.5 mg.$ and the metaphosphoric acid filtrate was
submitted to HgS reduction under the conditions mentioned by
the aforesaid authors, only 30$ of the dehydroascorbic acid
+ Dehydroascorbic acid was prepared either by aeration in
presence of copper or according to Patterson ( 79 ).
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could be recovered as ascorbic acid by the indophenol method.
The reason for such low recovery is that the pH of the meta-
phosphoric acid filtrate is approximately 1.5 and at that pH
HgS does not reduce dehydroascorbic acid quantitatively,
ievenson, Rosen, and Hitchings ( 91 ) also reported such low
recoveries of DHA at pH 1.5. At this stage, the recoveries
of known amounts of DHA, added to plasma, were determined in
metaphosphoric acid filtrates at pH 3.5 and 37° according to
levenson et al. ( 91 )• At the level of 1.0-1.5 mg. of DHA
per 100 ml. plasma the recoveries were 100-1025$. Stewart et
al. ( 83 ) have reported that human plasma contains 0.07-0.3
mg.5$ of DHA. When HgS recoveries were determined at the
latter levels, under the conditions of Levenson et al., con¬
sistently higher recoveries were obtained. Since HgS reduces
many other substances besides DHA ( 92 ) such anomalous
results may be expected, and small amounts of DHA cannot be
estimated accurately in the presence of biological materials
by its use. The next choice of reducing agent was Esch. coli
as applied by Mapson and Ingram ( 88 ) and Stewart et al. ( 86 ).
In Table lb are presented the analyses for ascorbic acid and
total ascorbic acid by the indophenol, phenylhydrazine, and
Esch. coli methods in the plasma of rabbits whose diets were
supplemented with cabbage. The results are almost similar to
those in Table la and need no further comment. At this point
attempts were made to reduce dehydroascorbic acid, added to
rabbit plasma, by Esch. coli. It was observed that the same
culture of Esch. coli which reduced DHA quantitatively in
TABLE lb
Concentrations of Ascorbic Acid and Total Ascorbic Acid in




Very high cabbage Cabbage ad libitum every day of the week.
Medium cabbage Cabbage ad libitum thrice a week
Rabbit Body Indophenol DHA Phenyl- Esch.coli Treat¬




g. mg. per mg. per mg. per mg. per
cent cent cent cent
14 1940 1.07 -0.09 0.98 0.662
15 1730 0.6 -0.14 0.46 0.426
Medium
21 1980 1.2 +0.02 1.22 1.0
cabbage
22 2000 1.1 -0.1 1.0 0.925
11 2050 1.07 -0.02 1.05 1.1
13 1850 0.8 + 0.02 0.82 0.75
0.65
Very
19 2500 0.65 0 0.6
^ mI.
17 1100 3.25 -0.4 2.85 3.05
nigix
cabbage
18 2200 2.25 -0.05 2.2 2.0
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aqueous solutions failed to do so in the presence of plasma.
In view of the latter finding no further attempt was made to
estimate DHA by the difference between the indophenol and Esch.
coli values.
Since the above experiment failed to show whether there was
any interference due to the cabbage factor, another attempt
was made to analyze the plasma of rabbits,which were deprived
of cabbage for different lengths of time, for ascorbic acid and
total ascorbic acid. The data are shown in Table 2. It is
clear that the results show the same trend as those in Table
la and Table lb. This experiment partially, but not wholly,
excludes the possibility of interference by the cabbage factor.
To exclude such a possibility completely, it was deemed necess¬
ary to analyse the cabbage for ascorbic acid and total ascorbic
acid by the indophenol and phenylhydrazine methods. The results
were as follows:
Indophenol method : : : 40.4 mg. AsA per 100 g.
Phenylhydrazine method : ; 42.5 mg. AsA per 100 g.
The above experiment shows that the phenylhydrazine value is
higher than the indophenol value in the cabbage. These results
in common with those in Table 2 negate the idea that the higher
indophenol values than the phenylhydrazine values in the plasma
of rabbits, whose diets were supplemented with cabbage, (Tables
la and lb), were due to interference by some substance from
cabbage.
TABLE 2
Concentrations of Ascorbic Acid and Total Ascorbic Acid























13 1330 0.475 +0.025 0,5 Complete deprivation
of cabbage for 5
days
14 1500 0.525 0 0.525 Same
15 1300 0.375 -0.125 0.25 Complete deprivation
of cabbage for 7
days
16 2000 1.02 -0.02 1.0 Same
20 2000 0.225 +0.125 0.35 Complete deprivation
of cabbage for 15
days
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It was considered important to know whether results similar
to those in Tables la, lb, and 2 could be obtained in the
plasma of rabbits whose diets were supplemented with synthetic
ascorbic acid instead of cabbage. The data are shown in Table
3. These results show that the phenylhydrazine values are
higher than the corresponding indophenol values in all cases
but one. It should be pointed out in this context that the
results of this experiment do not necessarily suggest that
since cabbage was excluded from the diet of these animals and
there was no interference from the cabbage factor, therefore,
the phenylhydrazine values were higher than the indophenol
values. If there was any interference with the indophenol
method by the cabbage factor then it v/ould have been detected
when ascorbic acid and total ascorbic acid estimations were
done in the cabbage by the indophenol and phenylhydrazine
methods. Lack of specificity of one or both the methods of
ascorbic acid estimation appears to be the explanation for the
observed difference between the results of ascorbic acid
estimation in the plasma of rabbits fed on cabbage and those
fed on synthetic ascorbic acid. Since the phenylhydrasine
method measures both dehydroascorbie acid and diketogulonic
acid it is difficult to decide whether the higher phenyl-
hydrazine values than the indophenol values ( Table 3 ) are
due to dehydroascorbic acid or diketogulonic acid. Because
of the lack of specificity of the H2S reduction it cannot be
applied to differentiate between the two substances (when
present in such small amountsl Further along the text this
TABLE 3
Concentrations of Ascorbic Acid and Total Ascorbic Acid in




Rabbit Body Indophenol DHA Phenyl- Treatment
So. Weight method „ hydrazine
method
AsA Total AsA
g. mg. per mg. per mg. per
cent cent cent
20 - 0 +0.25 0.25 10 mg. AsA/day for
7 days
21 - 0.4 +0.35 0.75 10 mg. AsA/day for
7 days
23 - 0.4 +0.175 0.575 10 mg. AsA/day for
5 days
75 mg. AsA/day for
2 days
50 mg, AsA/day for
5 days
24 1400 1.15 +0.175 1.325 50 mg. AsA/day for
15 days
54 - 0.35 +0.15 0.5 50 mg. AsA/day for
17 days
55 0.5 0 0.5 Same
56 0.125 +0.195 0.32 Same
48 0.95 +0.18 1.13 Same
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difference between the phenylhydrazine and indophenol values
will he referred to as " apparent dehydroascorbic acid tt.
There is no specific direct method available for the accurate
estimation of small amounts of dehydroascorbic acid in
biological materials* Hence it is almost impossible to supply
an incontrovertible proof for the existence of small amounts
of dehydroascorbie acid in. biological materials* The preced¬
ing experiments have pointed out the limitations of indirect
procedures for the measurement of small amounts of dehydro¬
ascorbic acid. Nevertheless, if consistently higher values
had been obtained by the phenylhydrazine method than by the
indophenol method then it could have been stated, with some
reserve, that the differences were due to dehydroascorbic
acid. Since the phenylhydrazine values are not significantly
higher than the indophenol values in the majority of eases,
except those reported in Table 3, it cannot be concluded
that dehydroascorbic acid exists in rabbit plasma.
At this stage, it was decided to investigate the effect of
alloxan injection, if any, on the level of " apparent
dehydroascorbic acid n in the plasma of rabbits whose diets
were supplemented with synthetic ascorbic acid. The results
of such estimations are presented in Table 4* Since alloxan
disappears from the circulation within a few minutes ( 93,94 ),
it was thought that any change in the ascorbic acid concentration
in the plasma would be manifested within a short time after
alloxan injection. Bearing this in mind, the first experiment
TABLE 4
Concentrations of Ascorbic Acid, and Total Ascorbic Acid in
the Plasma of Babbits Injected with Alloxan and Maintained
on a Diet Supplemented with Synthetic Ascorbic Acid

































50 mg. AsA/day for
15 days. Deceived
200 mg/Kg. alloxan
in one inj. Blood
taken 15 min. after
inj.
50 mg. AsA/day for
15 days. Eeceived
400 mg. alloxan in
3 inj. over a per¬
iod of 7 days.
Blood taken on 4th
day after last inj.
50 mg. AsA/day for
15 days. Eeceived
660 mg. alloxan in
4 inj, over a per¬
iod of 11 days.
Blood taken on 5th
day after last inj.
50 mg, AsA/day for
23 days. Eeceived
200 mg./Kg. alloxan
in one inj. Blood
taken on 4th day
after last inj.
50 mg. AsA/day for
25 days. Eeceived
200 mg./Kg. alloxan
in one inj. Blood
taken on 6th day
after last inj.
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was done on rabbit Bo. 12 which received 200 mg./Kg, of
alloxan in a single infection and "blood was drawn by cardiac
puncture 15 minutes after the completion of the injection for
ascorbic acid analyses# When indophenol was added to the
plasma filtrate of the above rabbit the spectrophotometer
indicated a very rapid fading of the residual color of the
indophenol within 30 seconds and afterwards. The rate of
fading in the above case was far quicker than the rate of
fading of indophenol when standard ascorbic acid was added
to the latter. Also the filtrate when incubated with phenyl-
hydrazine formed a precipitate which was insoluble in 85$
HgSO^. As a result of which the phenylhydrazine method
gave very low value ( see Table 4 )» On subsequent invest¬
igation it was found that when alloxan ( an amount that
would be present after injection of 200 mg./Kg., assuming
no loss and the blood volume to be 100 ml. per 1000 g, body
weight ) was added to pure ascorbic acid solution ( 1 rag.$ )
and the same solution was estimated by the indophenol and the
phenylhydrazine methods, 35$ higher ascorbic acid was recovered
by the indophenol method; 43$ lower ascorbic acid was recover¬
ed by the phenylhydrazine method. In view of this it is sur¬
prising that Siliprandi ( 95 ) using the indophenol method of
Mindlin and Butler ( 96 ) could observe a fall in the ascorbic
acid concentration immediately after alloxan injection. Ho
mention has been made by the above author of any interference
with the indophenol method under the above condition. Another
very curious thing that does not escape notice is that
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Siliprandi could observe the presence of alloxan in blood
for more than an hour. The latter finding is quite con¬
trary to the well established fact that alloxan is destroyed
within a few minutes after injection ( 93»94 ). In view of
this interference with the indophenol and phenylhydrazine
methods by some reduction product of alloxan, possibly
dialuric acid ( 82,94 )» no further attempt was made to
measure --corbie acid within a short period after alloxan
injection.
However, it was of interest to observe the level of " apparent
dehydroascorbic acid " in the plasma of diabetic rabbits.
Ascorbic acid and total ascorbic acid analyses in the plasma
of rabbits lo. 8, 7, 4, and 3 ( Table 4 ) were done after the
rabbits were diabetic for different lengths of time. In con¬
trast to the results in Table 3» those in Table 4 show that
although the rabbits are maintained on synthetic ascorbic
acid there is no " apparent dehydroascorbic acid n in their
plasma. Often the indophenol values are significantly higher
than the corresponding phenylhydrasine values. These figures
could be interpreted as indicating a possible removal of
dehydroascorbic acid accompanying the diabetes produced by
previous alloxan injection, and such an interpretation would
have a number of interesting consequences. However, if alloxan
exists in significant amount in the blood of diabetic animals
as has been suggested by Loubatiers ( 78 ) the above type of
results may be expected on that account and this seems a more
probable explanation. Certainly there is nothing to suggest a
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productlon of dehydroascorbic acid in permanently diabetic
rabbits and this is really the significant point.
PAET II
STUDIES OH THE IQDOMEIBIC MP GLYOXALASE METHODS FOR THE
ESTIMATION OF GLUTATHIPEE HT BLOOD ADD TISSUES
PART II
Studies on the Iodometric and Glyoxalase Methods for the
Estimation of Glutathione in Blood and Tissues:
INTRODUCTION
The methods for the estimation of glutathione in "blood and
tissues oan "be classified, according to the types of reagents
used, as follows: ( a ) Iodine ( 99-106), ( "b ) Nitroprusside
( 107-111), ( c ) Ferricyanide ( 112, 113 )» (d) Arsenophos-
photungstic acid ( 114, 115 ), ( e ) Phospho-18-tungstic acid
( 116), ( f ) Glyoxalase ( 117, 118 ), and ( g ) Silver nitrate
( 119, 120 ).
Although glutathione can he estimated accurately, in pure solut¬
ions, hy most of the above methods, only the glyoxalase method
is reliable when applied to "biological materials. Substances
which usually interfere v/ith the glutathione estimation, in
biological materials, by one or the other methods mentioned
above are uric acid, ascorbic acid, cysteine, ergothioneine,
and phenols. The glyoxalase method is claimed to be entirely
free from interference by any of the above mentioned substances
( 47, 117 ). The specificity of glutathione in the glyoxalase
system depends on the reduced form of the intact tripeptide
( 60, 117, 134 ). In the 1930's Lohmann ( 47 ) showed that
glutathione acts as a coenzyme in the glyoxalaae system and the
enzyme activation is dependent, within a certain range, upon the
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glutathione concentration. Woodward ( 117 ) exploited the
idea and developed a manometric procedure for the estimation
of glutathione ( GSH ) in "blood and tissues# At that time she
could not employ this method for the estimation of oxidized
glutathione ( GSSG ), after reduction of the latter "by metals,
"because of the toxicity of most of the metals towards glyoxalase
or because of incomplete reduction of the oxidised glutathione
by the metals. However, in 1939 Dohan and Woodward ( 113 )
successfully reduced GSSG by electrolytic reduction and showed
by recovery experiments that the GSSG can be estimated quantitat¬
ively in biological materials by the combined use of electro¬
lytic reduction and the manometric method# In that paper they
reported that the GSH content of :lood and tissue filtrates
of rats and rabbits remained the same before and after electro¬
lytic reduction and it was concluded that blood and tissues
do not contain any oxidised glutathione. It is interesting to
note that a similar suggestion had been made previously by
funnicliffe (99 )• However, Thompson and Voegtlin ( 100 ) who
used Tunnicliffe's iodometric method of glutathione estimation
and employed metallic magnesium for the reduction of GSSG in
blood and tissue filtrates, observed a 5$ increase in the titrat¬
ion values after Mg reduction and concluded that most of the
glutathione exists in the reduced form and less than 10$ is pres¬
ent in the oxidised form. At a still later date, Sehelling ( 113 )
used the more specific ferricyanide method of Mason ( 112 ) for
the estimation of glutathione. He subjected 1:5 Folin-Wu blood
filtrates to nascent hydrogen reduction with Mg powder and observed
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a definite increase in* thiol values ( sometimes 100#) after
such reduction? hut he was not convinced that the increase
was du.e to the reduction of GSSG. Schelling did not make any
definite comment on the presence or absence of the oxidized
glutathione hut ascribed the higher thiol values after Mg*
treatment to the reduction of some other substances besides
glutathione which were interfering with the method. Fujita
and Humata ( 105» 110 ) applied HgS for the reduction of GSSG
in blood and tissue filtrates and estimated the total gluta¬
thione by the iodometric and nitroprusside methods. »They
reported the presence of considerable amounts of GSSG in
blood and tissues. Dohan and Woodward ( 118 ) criticized the
work of Fujita and Humata ( 105 ), on the basis of their find¬
ing that HgS is retained in the dilute (1:20 ) filtrates and
such traces of IIcan consume sufficient iodine to lead to
considerable errors when the results are calculated as GSSG
per 100 g, of tissue. However, a number of other papers have
appeared on the glutathione contents of tissues and blood
( 121-123, 133, 179 ) since the publication of Dohan and Wood¬
ward's paper? but there is no general agreement on the question
of the existence of oxidized glutathione in tissues and blood.
This warranted a reinvestigation of the problem.
+ The word "thiol" is used rather loosely in this text to





Glyoxalase method for tlie estimation of GSH:
The method of Woodward ( 117 ) was used with minor modifications.
Beagents:
A. Acetone dried yeasts
Fresh "baker's yeast ( Distillers Co. Ltd., Edinburgh ) was dried
according to Albert, Buehner and Bapp ( 129 ) and stored in the
ice box. The yeast was rendered glutathione-free before use by
suspending 2-3 g. of acetone dried yeast in 80-90 ml. of distilled
water and centrifuging. The procedure was repeated three times.
Finally the washed yeast was made up as 33-36$ suspension in
water ( the concentration of yeast was chosen such that with 0.5
ml. of 20 mg.$ standard glutathione solution it produced approxi¬
mately 200 microliters of COg in 20 minutes ).
B. 1$ Methyl glyoxal ( pyruvic aldehyde ) ( L. Light and Co. Ltd.,
Bucks, England ). Made by diluting a 30$ aqueous stock solution.
C. 0.2 I sodium bicarbonate. ( A.R. ) ( B.D.H. ).
D. 0.8 M sodium bicarbonate. ( A.R. ) ( B.D.H. ).
E. 3$ ( w/v ) sulfosalicylie acid ( B.D.H. ).
F. Glutathione. ( Yeast Research Outetation, Distillers Co, Ltd.,
Glenochil, Menstrie, Clackmannanshirej and Distillers Co.
(Bioehemicals ) Ltd., Fleming Road, Speke, Liverpool ).
A fresh 20 mg.$ ( w/v ) stock glutathione ( purity 99.8$ ) solution
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was prepared every day. The stock solution was diluted to make
5 and 10 mg.$ solutions.
The glyoxalase activity was measured at 25° in a circular Warburg
machine. Warburg flasks with a single sideara. ( capacity
0,8-1.0 ml. ) and a total volume of 15-16 ml. were used. The
following were pipetted into the nain chamber of each flask:
0.5 ml. of yeast suspension, 0.2 ml. of methyl £yoxal, 0.4 ml.
of 0.2 M sodium bicarbonate, and water to make the total fluid
volume, including the measurements in the sidearm, to 2 ml. 0.5
ml. of standard solutions containing 5, 10, 20 mg. of glutathione
per 100 ml, were measured into the sidearms respectively. The
standard glutathione solutions were not neutralized, 0.5 ml. of
3$ sulf©salicylic acid ( SSA ) blood or tissue filtrate was neutral'
ized in the sidearm with 0,3 I sodium bicarbonate ( the requisite
amount being determined by & separate titration using methyl orange
as an indicator )® The standards and the unknowns were run in
duplicate.
In running a typical estimation the following procedure was
adopted: All the reagents for the main chamber were pipetted
first. The standard solutions of glutathione and the requisite
amounts of 0.8 M ITaHCO^ ( for the neutralisation of the sulfo-
salicyclie acid filtrates ) were measured into the sidearras.
The flasks containing the standard solutions were fitted to the
manometers. The unknown filtrates were pipetted into the side-
bulbs and the flasks were immediately fitted to the manometers.
The manometers and the vessels were flushed with a mixture of
95$ H2 and 5$ C02 for 15 minufc es at 25°. After gassing, the
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manometers and the vessels were shaken for 1 minute. At the end
of which the contents of the side-bulbs were tipped in and the
shaking continued for 4 minutes v/ith the stop-cocks of the mano¬
meters open. The shaking mechanism was stopped, the stop-cocks
were closed and the fluid levels of the manometers were adjusted
such that the left hand columns read between 0-20 mm. Shaking was
resumed again and readings were taken at 5 minute intervals for 25"
minutes without stopping the shaking mechanism. The first five
minutes readings were discarded. A calibration curve was construct¬
ed by plotting the microliters of COg evolved in 20 minutes against
the glutathione concentrations. The unknowns were read off from the
curve and the glutathione concentrations calculated according to the
dilutions of the filtrates. The concentration of glutathione in the
unknoY/ns was kept limited to 10 mg. of glutathione per 100 ml.
A yeast blank v/ith no glutathione Y/as included in each estimation
and the readings of the standards and the unknowns were corrected
for blank gas evolution. When the number of unknowns were greater
than that could be accommodated with the standards, then a separate
yeast blank was repeated with the unknowns.
Iodometric estimation of G-SH and GSSG:
The method of IoodY/ard and Fry ( 101 ) was followed.
Electrolytic reduction for the estimation of oxidized glutathione:
3$ sulfosalicylic acid ( SSA ) blood and tissue filtrates were sub¬
jected to electrolytic reduction as described by Dohan and Woodward
( 118 ). After electrolytic reduction the total glutathione
estimations were done by the glyosalase and iodometric methods.
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The details of the electrolytic reduction will he described in
the appropriate sections*
Choice of Sulfosalic.vlic Acid Concentration for the Electrolytic
Seduction of Blood Filtrates;
In a few preliminary experiments it was observed that when 5 ml.
of 1*5,2$ sulfosalicylie acid blood filtrate were reduced for
10 minutes with a current density of 4*26 milllamperes per sq.
cm,, the filtrate became alkaline to methyl orange. If gluta¬
thione estimation was done in such a filtrate by the giyoxalase
method, the GSH value \ms considerably lower after than before
reduction ( fable 5a ).
Unfortunately, the exact pH values of the above filtrates after
the reduction were not measured5 since the filtrates were
alkaline to methyl orange the pH values must have been above 4,0,
At this stage, it was decided to determine the exact pH values,
of blood filtrates before and after reduction, using various acid
concentrations and reduction conditions* The results of such

















VolumeCathodeSaltCurrentTi f reducedvesselbridgd nsityreduction diameterborcurr nt
area
Blood filtrate1:5 Liver filtrate (I
T






5 5 5 5 5 5
cm. 3.5 3*f3.6 3.6 3.6 3.5 3.5 3.5 3.6 3.6 3.6 3.6 3.6 3.6
mm. 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5
milli-i li- amperes persq.cm,
2.49
24 24 44 44 44 24 24 24 44 44 44 44 44 44
2.49 4.32 4.32 4.32 2.49 2.49 2.49 4.32 4.32 4.32 4.32 4.32 4.32
min, 20 20 10 10 10 20 20 20 10 10 10 10 10 10
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above table that the pH values of 2$ and 2•% SSA blood filtrates
rise above 3*0 even after reduction with a low current density
of 2.49 milliamperes per sq. cm. and with a high current density
of 4.32 milliamperes per sq. cm. the pH values go near or above
4»0. It should also be noted that both the initial and the
final pH values show wide variation. Such variations may be
expected because of the fact that different blood samples have
varying buffering capacities, which influence both the initial
pH and the pH after reduction. Woodward and Fry ( 101 ) showed
that glutathione undergoes considerable autoxidation within an
hour at pH values over 3»0<, Table 5b shows that the pH values
of 2.3?5 SSA blood filtrates rise above 3.0 under all conditions
of reduction; specially when the filtrates were reduced with a
high current density the pH values ranged from 3.5-5.68. Talcing
the above factors into consideration it is not surprising that
some loss of G-SH was observed after electrolytic reduction with a
high current density ( Table 5a ). Furthermore, it should be
noted in the latter table that the loss of G-SH is not the same
in all the cases. This is in harmony with the fact that filtrates
show wide variation of pH values after reduction (Table 5b ),
therefore, the loss of GSH shall not be the same in all cases.
It will be shown later, where reduced and total glutathione
( after electrolytic reduction with a low current density )
estimations were done by the glyoxalase method, on the same sample
of blood deproteinised by 2.3/5 or 3fo SSA, the oxidised glutathione
value was lower in the former than in the latter.
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During an experiment in which several reductions are done, the
filtrates stand for an hour or more after the electrolytic
reduction} "before the total glutathione contents are estimated
manometrieally. Since the above results indicate that loss of
GSH occurs, after electrolytic reduction, in 2$ or 2*3$ SSA "blood
filtrate, it .is not safe to submit such filtrates to the electro¬
lytic reduction if the total GSH is to be estimated by the glyox-
alase method. In view of the fact that 3$ SSA blood filtrates
maintain the pH around 2.0 at high or low current densities
( fable 5b ) and at that pH no loss of GSH occurs for a consider¬
able length of time ( 101 ), 3$ SSA is preferable to 2$ or 2.3$
SSA. During the course of this work numerous 3$ SSA blood
filtrates were reduced with high and low current densities, and
although the exact pH values were not measured in each case,
none of the filtrates became alkaline to methyl orange.
Effect of pH on the Electrolytic Reduction:
Portions of 3$ SSA were brought to pH 0.8, 1.0, 1,2, 1,4, 1.6,
1.8, and 2.0 by means of dilute HC1 and KagHPO^. Oxidised
glutathione was added to these solutions to make a final con¬
centration of 20 rag, of GSSG per 100 ml. 5 ml. of each solution
were reduced for 10 minutes with a current density of 4*32 milli-
amperes per sq* cm. and the degree of reduction was determined by
the iodoraetric method. 100$ reduction was observed in all cases.
When the above solutions were left after the electrolytic re¬
duction for 12 hours, 13-17$ loss of GSH was observed at pH 2
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( pH 3.5 after reduction ), while in the others only 2-3$ loss
of GSH occurred, fliis experiment shows that there is no optimum
pH for the electrolytic reductions it proceeds equally well at
all pH values# This is in substantial agreement with Dohan and
Woodward ( 118 )$ they found the same degree of reduction in
1.8-3#4$ sulfosalicylic acid concentrations.
Recoveries of Seduced and Oxidized Glutathione from Different
Media "by the Glyoxalase Method;
The recoveries of reduced glutathione, when the latter was added
to plasma or whole blood, "by the glyoxalase method, are presented
in Table 6# The average recovery from the plasma is 98# 6$ ( range
95-100$ ) and from the whole blood is 97*4$ ( range 93-102$ ).
Talcing into consideration the various factors which influence the
glutathione estimation by the above method the recoveries are
quite good# Table 7 presents the recoveries of oxidised gluta¬
thione, when the latter was added to plasma, by the combined use
of electrolytic reduction and the glyoxalase method of estimation.
Quantitative recoveries are obtained with current densities of
2.49, 4*26, and 4.32 mllliamperes per sq. cm. It can be seen from
the latter table that similar recoveries are obtained from both 3$
and 2.4$ sulfosalicylic acid filtrates. This is due to the fact
that Is5 plasma filtrates of 2.4$ SSA have lower pH than 1:5 blood
filtrates of the same acid, and consequently plasma filtrates do not
become as alkaline as blood filtrates under similar conditions of re¬
duction. When H2O2 was used as an oxidising agent for the GSH ( 130 )
sometimes very low recoveries ( 88—90$) of GSSG were obtained, possibly
TABLE6




















































































Recoveries of Oxidized Glutathione from Plasma by the Glyoxalase Method and Electrolytic Reduction
GSH - Reduced glutathione GSSG - Oxidized glutathione
Media Oxidiz¬ GSSG GSSG Estimat¬ Recovery Conditions of reduction
ing added calcul¬ ed as

















Blood H202 25 25 23.75 95 3 5 3.5 4.5 41 4.26 10
Plasma
1:5
ft n2°2 50 50. 49.3 98.7 3 5 3.5 4.5 41 4.26 10
ft H2O2 50 50 48.7 97.5 3 5 3.5 4.5 41 4.26 10
ft H202 30 30 28.7 95.6 2.4 5 3.5 4.5 41 4.26 10
n H202 30 30 29.0 96.6 2 .4 5 3.5 4.5 41 4.26 10
n E2°2 25 25 22.5 90.0 3 5 3.5 4.5 41 4.26 10
tt H202 25 25 ■ 23.1 92.4 3 5 3.5 4.5 41 4.26 10
ft 12 50 50 50 100 3 5 3.5 4.5 41 4.26 10
tt *2 30 30 28.8 96 3 10 3.5 4.5 24 2.49 20
tt 12 30 30 30 100 3 10 3.5 4.5 24 2.49 20
tt 12 30 30 31 103 3 10 3.5 4.5 24 2.49 20
ft 12 50 50 50 100 3 10 3.5 4.5 24 2.49 25
it 12 50 50 50.5 101 3 10 3.5 4.5 24 2.49 25
tt I2 50 50 49.0 98 3 5 3.5 4.5 44 4.32 10tt 12 50 50 50 100 3 5 3.5 4.5 44 4.32 10
ti 12 50 50 47.5 95 3 5 3.5 4.5 44 4.32 10
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due to tlie oxidation of GSH beyond the disulfide stage. However,
when GSH was oxidized \,/ith the theoretical amount of N/100 iodine
solution, uniformly good recoveries were obtained. The presence
of HI does not interfere with the glyoxalase method.
Recoveries of Oxidized Glutathione from Blood. Plasma, and
Aqueous Solutions after Zinc Reduction by the Iodometric Method
GSSG was added to plasma or whole blood to give oxidized gluta¬
thione concentrations of 10, 15, 30 mg. per 100 ml. and the
solutions were made protein-free by 3$ SSA. 10 ml. of the 1:5
SSA filtrates were submitted to Zn reduction for 30 minutes,
The amount of reduction was checked through iodate titration.
It was observed that only 69$ of the added GSSG could be recovered
as GSH from the blood filtrates and 52$ from the plasma filtrates.
Such inability of zinc to reduce GSSG quantitatively in the pres¬
ence of plasma or serum filtrate has been observed by Dohan and
Woodward ( 118 ). In common with them, it has been observed in
the course of this work that zinc can bring about 100$ reduction
of GSSG in aqueous 3$ SSA solution; because of the low recover¬
ies from blood or plasma and since zinc reduced samples cannot be
used for the estimation of total glutathione by the glyoxalase
method ( zinc reduced samples are toxic to the glyoxalase ),
electrolytic reduction,which gave complete recovery, was ultimate¬
ly adopted as the standard procedure.
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Investigations on the Presence of Oxidized Glutathione In Blood:
Human Blood:
Dohan and Woodward ( 118 ) mentioned in their communication that
the oxidised glutathione can "be reduced hy electrolytic reduction
to GSH and the latter can he estimated hy the glyoxalase method
as well as hy the iodometrie method ( 101 ). Furthermore, they
recovered added GSSG quantitatively from red hlood cells and red
hlood cell filtrates hy the combined use of electrolytic reduction
and the iodometric method of estimation. It is rather surprising
that no attempt was made hy the ahove authors to estimate any
oxidised glutathione that might normally he present in hlood hy
the latter procedure. In some pilot experiments 3$ sulfosalicylic
acid hlood filtrates were subjected to electrolytic reduction and
the glutathione values before and after reduction were estimated
hy the glyoxalase method. Consistently higher GSH values were
observed after than before reduction. It was of interest, there¬
fore, to make a comparative study on various hlood samples de-
proteinized hy 3$ 3SA, reduced eleetrolytically or hy zinc, and
estimating the reduced and total glutathione values hy the iodo¬
metric and glyoxalase methods.
fhe following experimental procedure was adopted: "Venous hlood
samples from normal subjects and hospital patients were drawn in
heparinised syringes and immediately upon collection the samples
were deproteinized. For deproteinization 1 volume of non-hemolyzed
hlood was added very slowly with agitation to 4 volumes of %
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sulfosalicylic acid and the mixture was thoroughly shaken.
Since the "blood was not hemolyzed prior to deproteinization,
thorough shaking was essential to ensure complete extraction of
the glutathione from the disintegrated corpuscles. Glutathione
and total glutathione ( reduced plus oxidized glutathione )
estimations were done on aliquots of the same filtrate as
follows: GSH was estimated "by the iodometric { 101) or glyoxal-
ase method. A 10 ml. portion of the filtrate was reduced "by 30-40
mg. of zinc dust and the total glutathione was estimated by the
iodometric method. Another 10 ml. of the filtrate were subjected
to electrolytic reduction with a current density of 2.49 milli-
amperes per sq. em. for 20 minutes. 5 ml. of the reduced sample
were titrated with iodate and in the remaining filtrate total
glutathione was estimated by the glyoxalase method.
In order to clarify the arguments in this section, several observed
facts have been recalled here. The iodometric method is non¬
specific for GSH estimation and zinc does not reduce GSSG quantit¬
atively in blood or plasma filtrate; on the other hand, the
glyoxalase method is speoific for the estimation of glutathione
and the GSSG is quantitatively reduced by the electrolytic re¬
duction in the presence of biological materials. Table 8
presents the analyses for reduced and total glutathione, in
different blood filtrates, by various methods. It can be seen
from the latter table that the thiol values increase after electro¬
lytic reduction, irrespective of the method of estimation. It
might be argued that the increases in thiol values after Zn
TABLE8
GlutathioneAn lysesofHumanBlo dbyV ri usMetho
GSH-ReducedglutathioneG SGox d^eAglu athione Sheresultsarexp essedinmg.rc nt




















































































































































































or electrolytic reduction, as estimated by the iodometric
method, may he due to substances other than glutathione.
However, reference to Sable 8 shows that out of the sixteen
cases studied only in two cases ( ITo. 15 and 16) the gluta¬
thione values, as obtained by the glyoxalase method, remained
the same before and after electrolytic reduction. On the other
hand, in the same two cases the thiol values obtained by the
iodometric method are higher after than before electrolytic
reduction. In those two cases in question, therefore, the
increases in thiol values obtained after electrolytic reduction
by the iodometric method are in all probability due to substances
other than glutathione. In the rest of the cases, however, the
glutathione values obtained by the iodometric and manometric
methods are higher after than before reduction. Since the
glyoxalase method is extremely specific for the estimation of
glutathione, it can be assumed that the increases in thiol
values, as estimated after electrolytic reduction by the mano¬
metric method, are due to the reduction of oxidized glutathione.
Hence the increases in thiol values, estimated in common \yith
the glyoxalase method by the iodometric method, are also partly,
but not wholly, due to the reduction of oxidized glutathione.
The latter statement can be verified by comparing the results
obtained after Zn or electrolytic reduction by the iodometric
method with those obtained after electrolytic reduction by the
manometric method. Such comparisons are shown in Pig. 2-5, each
point in those figures represents the result of one estimation,
on the same filtrate, by each method. If the two methods give
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identical values then the points should fall on the line with
slope 1} if one gives higher results than the other then the
points would shift towards the method giving the higher results.
A similar comparative study has heen made in Fig, 1 between the
reduced glutathione values obtained by the iodometric method
and those obtained by the manometrie method. In the latter
figure the points are scattered almost equally on both sides of
the middle line, which implies that the methods agree well and
probably measure the same substance. Talcing into account the
extreme specificity of the glyoxalase method, it may be assumed
that the substance measured by both the methods is glutathione.
The total and oxidized glutathione values given by the iodo¬
metric method are higher than those obtained by the glyoxalase
method ( Fig. 2-5). The latter findings indicate that probably
during electrolytic and zinc reductions of blood filtrates,
substances other than oxidized glutathione are also reduced, and
when such filtrates are analyzed by the non-specific iodometric
method these interfering substances consume iodine thereby giv¬
ing falsely high glutathione values, but do not activate the
glyoxalase system. Since GSSG in the presence of protein is
100$ reducible by the electrolytic reduction but is only 70$
reducible by the Zn reduction, and interfering substances are
formed during both the reductions it might be expected that the
total and oxidized glutathione values obtained by the iodometric
method after electrolytic reduction of blood filtrates would be
higher than the corresponding values obtained by the same method
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FIG. I. A comparison between the reduced glutathione values
of blood obtained by the glyoxalase method and those
obtained by the iodometric method.
PIG. 2. A comparison "between the total glutathione values
of blood obtained after electrolytic reduction by
the glyoxalase method and those obtained after
zinc reduction by the iodometric method.
PIG-. 3. A comparison between the oxidized glutathione
values of blood obtained after electrolytic reduction
by the glyoxalase method and those obtained after
zinc reduction by the iodometric method.
FIG, 4. A comparison between the total glutathione values blood
obtained after electrolytic reduction by the
glyoxalase method and those obtained after electro¬
lytic reduction by the iodometric method.
FIG. 5. A comparison between the oxidised glutathione values
of blood obtained after electrolytic reduction by
the glyoxalase method and those obtained after
electrolytic reduction by the iodometric method.
PIG. 6. A comparison between the total glutathione values
of blood obtained after electrolytic reduction by
the iodometric method and those obtained after
zinc reduction by the iodometric method.
FIG. 7. A comparison "between the oxidized glutathione
values of blood obtained after electrolytic
reduction by the iodometrie method and those
obtained after zinc reduction by the iodometric
method.
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It can be concluded, therefore, that the iodometrie method is
reliable for the estimation of G-SH in blood filtrates, but is
unsuitable for the accurate estimation of total glutathione in
blood filtrates#
Babbit and Hat Blood;
Blood samples were collected in heparinised syringes from the
abdominal aorta of rats and by cardiac puncture from rabbits.
As soon as possible after collection the samples were deprotein-
Ized with 3$ sulfosalieylie acid as described for the human
blood# G-SH and total glutathione ( after electrolytic reduct¬
ion ) estimations were done by the glyoxalase method# The
electrolytic reduction was carried out as follov/s: 5 ml. of
the filtrates were reduced for 10 minutes with a current density
of 4*26 or 4*32 milliamperes per sq. cm. The results of this
experiment are presented in Table 9. It is evident from the
latter table that considerable amounts of GSSG are present in
all the samples and the rat blood contains significantly higher
amount of GSSG than the rabbit blood# The difference may be
attributable to the variation in the GSH content of the arterial
and venous blood (101, 131, 132 )# This explanation is not quite
tenable in the above oases, because blood samples were collected
from the rabbits by a technique, described in Part I, which en¬
sures puncture of the left ventricle, therefore, the blood samples
were arterial# However, there is another possibility that the
blood from different regions of the body may contain varying
TABLE 9
Glutathione Analyses of Babbit and Eat Blood by the
Glyoxalase Method
G-SH — Reduced glutathione GSSG — Oxid^ed. glutathione
The results are expressed in rag. per cent
Animal Ho. GSH GSSG Total GSH
Bat 1 16.3 21.2 37.5
n 2 16.3 23.4 39.7
n 3 22.3 25.0 47.5
M 4 16.9 20.6 37.5
n 5 18.8 19.9 38.7
n 6 17.5 20.5 38.0
Rabbit 1 22.5 6.8 29.3
ft 2 35.0 13.2 48.2
ft 3 30.0 13.0 43.0
ft 4 25.0 21.3 46.3
tt 5 24.0 12.0 36.0
ft 6 34.3 11.9 46.2
ft 7 22.4 7.3 29.7
W 8 43.1 10.9 54.0
H 9 24.0 16.0 40,0








Same after CO 30.6 16.9 47.5
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amounts of GSSG. In the absence of any experimental evidence
to support the later contention the difference is suitably ex¬
plained as due to the species variation.
Effect of Carbon Monoxide on the GSSG Content of Blood;
Uumata ( 132 ) observed that G-SE is oxidised during the deprotein-
iaation of blood with HPO^. He suggested that the protein pre¬
cipitation of blood or organs with high hemoglobin contents
must be done in an atmosphere of carbon monoxide to prevent such
oxidation, fbe recovery experiments of added GSH from the whole
blood ( fable 6 ) prove that no oxidation of GSH occurs during
the protein precipitation of blood with 3$ SSA. However, to be
absolutely sure that such is the case it was decided to estimate
the GSH and total glutathione in the same blood sample, treated
and non-treated with carbon monoxide before deproteinization, by
the giyoxalase method. The same experimental procedure was
adopted for the deproteinization and electrolytic reduction as
reported for the rabbit and rat blood. The results of two such
experiments with rabbit blood are presented in Table 9» It Is
interesting to note that both the GSH and total GSH values are
5-6 mg.$ higher in the carbon monoxide treated samples than in
the non—treated samples; but the GSSG values in the carbon
monoxide treated and non-treated samples are practically the
same. Incidentally it might be mentioned that aqueous solutions
of GSH, when estimated by the glyoxalase method, show the same
GSH contents before and after CO treatment. Experiments have
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not been done to investigate the nature of the interference
"by CO; because such an unphysiological level of CO ( 100$
saturation ) is not ordinarily encountered whereby the specif¬
icity of the manometric method may be jeopardized. However,
the significant point of this experiment is that the oxidized
glutathione values remain the same whether blood samples are
treated or not treated with CO before the deproteinization.
Miscellaneous Experiments:
These experiments were done with the hope that it might be
possible to find some explanation for the discrepancies between
the results of Dohan and Woodward ( 118 ) and the results report¬
ed here.
Glutathione and total glutathione estimations were done in
freshly dram human blood samples by the combined use of
electrolytic reduction and the glyoxalase method. Heparin was used
as an anticoagulant* The samples were deproteinized with 2.5$
or 3$ SSA as previously described for the human blood. 10 ml.
of Is5, 2.3$ or 3$ blood filtrate were submitted to electrolytic
reduction with a current density of 2.49 milliamperes per sq.
cm. for 20 minutes; the total glutathione estimations were done
as quickly as possible ( loss of GSH occurs if 2.3$ SSA filtrates
are allowed to stand after the electrolytic reduction ). Three
such experiments were done and the following, 2.3, 4*2, and 1.6
mg*$ G-SSG were observed in 2,3$ SSA filtrates; the correspond¬
ing G-SSG values in 3$ SSA filtrates were 5, 5.3, and 5.3 mg.$.
-48
These experiments support the previous contention that 2,3*$
SSA blood filtrates are unsuitable for the electrolytic re¬
duction 5 but they do not explain the inability of Dohan and
Woodward ( 118 ) to find any increase in GSH values of blood
filtrates after electrolytic reduction by the glyoxalase
method. It is most unfortunate that they concluded on the
basis of only two determinations that oxidized glutathione
does not exist in blood. In this context it should be pointed
outj of course, that Dohan et al. submitted 5 ml. of 1:5, 2.3$
SSA blood filtrates to electrolytic reduction with a current
density of 4.2 milliamperes per sq. cm* for 10 minutes? in
our experience such reduction conditions take the pH of these
filtrates to near 4 or above 4. As has been stated already,
we found considerable loss of GSH at the latter pH; it is
curious that Dohan et al. found no such loss. In the absence
of any information in the paper of the above authors about how
soon the estimations were done after electrolytic reduction,
it is difficiilt to draw any conclusion.
In the course of this investigation other factors were also
checked which might be responsible for the oxidation of GSH
during the deproteinization of blood. Since the mixture of
blood and 3$ SSA was shaken for the complete extraction of
GSH from the corpuscles, it was decided to check if such
shaking caused any oxidation of GSH. Samples of blood were
deproteinized with and without shaking and the GSH estimations
were done by the manometric and iodometric methods. It was
observed that thorough shaking was essential for the complete
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extraetion of G-SH from the disintegrated corpuscles and no
oxidation of the GSR occurs under such conditions#
Experiments were also done to find out if any oxidation of
GSH occurred between the collection and deproteinization of
blood samples. It has been found that the amounts of GSH,
GSSG, and total glutathione remained the same no matter whether
the blood samples were taken directly into 3$ SSA ( cooled to
0° or at room temperature ) or into a test-tube and then
pipetted into 3?» SSA.
She preceding experiments seem to exclude any possibility of the
formation of oxidised glutathione during the technical manipul¬
ations of blood samples, therefore, the GSSG, which is measured,
may be considered to exist preformed in the blood of human,
rabbits and rats.
Question of the Existence- of Oxidised Glutathione in Tissues:
A suitable amount of fresh tissue ( 0.5-0.8 g. of liver^0.4-
0.7 g. of pancreas ) was taken in 5-7 ml. of 3$ sulfosalicylie
acid and weighed. The sample was ground with acid washed
white sand in an all-glass mortar and pestle. The extraction
was repeated a few times and finally the whole coagulum was
transferred to a volumetric flask and made up to volume ( 25
ml. for liver and 10 ml. for pancreas ) with 3$ sulfosalicylic
acid. The extract was centrifuged and filtered. Glutathione
and total glutathione estimations were done by the glyoxalase
method. For the electrolytic reduction 5 ml. of the filtrate
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were reduced for 10 minutes with a current density of 4#32
milliamperes per sq.. ecu The pH of the filtrate, after
electrolytic reduction, under the above conditions, was below
1.5.
The analyses for reduced and total glutathione in liver and
pancreas of rats and rabbits are presented in Table 10. For
the sake of comparison a few results obtained by the iodo-
metric method after Zn or electrolytic reduction of the above
filtrates are also presented. It is evident from the above
table that the GSH values obtained by the iodometric method
are higher than the corresponding values obtained by the mano-
metric method. From these results it is concluded, that the
degree of interference by substances other than glutathione
is greater in tissue filtrates than in blood filtrates when
glutathione is estimated by the iodometric method. It is
surprising, however, that the thiol values show no rise after
Zn or electrolytic reduction when estimated by the iodometric
method; because the iodometric method is vulnerable to inter¬
ference by substances other than glutathione which might be
reduced in the course of Zn or electrolytic reduction. How¬
ever, taking into account that not very many estimations were
done, any attempt to draw any conclusion regarding the above
issue vd.ll be abortive. • In common with Woodward ( 117 ) these
results indicate that the iodometric method gives erroneously
high glutathione values in tissue filtrates. In agreement with
Sohan and Woodward ( 118 ) no consistent rise in the GSH values
TABLE10
GlutathioneAnalysesofTissuebVariousMeth d












































































































































of the liver and pancreas filtrates after electrolytic
reduction could he observed in this experiment. It might
he mentioned in this context that the pH values of the above
tissue filtrates were well below 2.0 even after electrolytic
reduction with a high current density of 4.32 milliamperes
per sq. cm. Lower concentrations of sulfosalicylic acid may
be used safely for making tissue extracts, without going into
the risk of talcing the pH above 3.0 after electrolytic
reduction.
It is concluded, therefore, that oxidized glutathione does
not exist in measurable amounts in the tissues studied in the
course of this investigation.
A comparative study on the iodometric and manometric methods,
for the estimation of glutathione in blood and tissues, has
been done. Both the above methods agree fairly well on the
values of G-SH in blood. However, for the accurate estimation
of total glutathione in blood the method of Dohan and Woodward
( 118 ) requires certain modifications. In the course of this
investigation it has been observed that 2.3$ sulfosalicylic
acid blood filtrate is unsuitable for the electrolytic reduct¬
ion; because the pH of the above filtrate rises above 3 and 4
when submitted to electrolytic reduction with current densities
of 2.49 and 4.32 milliamperes per sq. cm. respectively. Since
glutathione is autoxidizable at pH 3.0 ( 101 ), 2.3$sulfosalicylic
DISCUSSION
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acid blood filtrates are best avoided for the electrolytic
reduction. On the other hand, if yjo sulfosalicylic acid
blood filtrate is used for the electrolytic reduction, the
pH remains belov; 2.0 with a current density of 2.49 milli-
smperes per sq. cm. and goes little above 2.0 with a current
density of 4.32 milliamperes per sq. cm. At pH 2.0 gluta¬
thione is stable for a considerable length of time ( 101 ),
Hence 3$ sulfosalicylic acid is preferable to 2,3$ sulfo-
salicylic acid for making blood filtrates if the total gluta¬
thione values are to be estimated after electrolytic reduction
by the manometric method. Using this modification consider¬
able increases in the GSH contents of blood filtrates were
observed. In view of the specificity of glutathione in the
glyoxalase system it is reasonable to assume that glutathione
is responsible for the Increases in the thiol values.
Although Dohan and Woodward ( 118 ) could recover added GSSG
quantitatively from red blood cell filtrates and red blood
cells by the combined use of electrolytic reduction and the
iodometric method of estimation, no attempt to estimate any
oxidized glutathione that might normally be present in blood,
by the above method was made by the aforesaid authors. In the
course of this work confirmatory evidences, regarding the
presence of oxidised glutathione, were sought by submitting
blood filtrates to electrolytic or Zn reduction and estimating
the thiol values ty the dodaie titration. Increases in thiol values
of blood filtrates were observed consistently after Zn or
-53-
electrolytic reduction, irrespective of the method of estimat¬
ion. Since the iodometric method is not specific for the
estimation of glutathione, the results given "by the latter
method were compared with those given "by the manometric
method ( Fig. 2-5 ). If the ratio of the total glutathione
value obtained by the iodometric method after Zn or electro¬
lytic reduction to that obtained by the manometric method
after electrolytic reduction had been unity, then it could
be concluded that in all probability the substance which was
measured by both the methods was oxidized glutathione. Fig.
2-5 show that such is not the ease. The total glutathione
values obtained by the iodometric method after Zn or electro¬
lytic reduction are higher than the corresponding values
obtained by the glyoxalase method after electrolytic reduction,
xvhich suggests that when blood filtrate is reduced by Zn or
electrolysis, other substances are reduced along with the
oxidized glutathione and those interfering substances consume
iodine, thus falsely high total glutathione value is obtained.
It can be concluded, therefore, that the increases in thiol
values of blood filtrates as estimated by the iodometric method
after Zn or electrolytic reduction are partly, but not wholly,
due to the oxidized glutathione. Hence the iodometric method
is unreliable for the accurate estimation of oxidized gluta¬
thione In blood.
Experiments of different sorts were done to exclude the possibil
ity that the oxidised glutathione as measured by the manometric
method was formed during the technical manipulation of blood
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samples. All those experiments negatived such a possibility.
These experiments strongly suggest that oxidized glutathione
exists preformed in human, rat, and rabbit blood.
In contrast to blood, however, in tissues no measurable
amount of oxidized glutathione could be detected. This find¬
ing confirms that of Bohan and Woodward ( 118 ) and Herrmann
and loses ( 179 )♦ In agreement with Wood?/ard ( 117 ) these
experiments show that the iodometric method gives erroneously
high glutathione values in tissue filtrates. Ennor ( 153 )
on the other hand, found close agreement between the GSH
values of tissue extracts obtained by the manometric method
and those obtained by the iodometric method. He considered
that Woodward ( 117 ) obtained low G-SH values in the tissue
filtrates by the glyoxalase method, because of the toxicity
of sulfosalicylic acid towards glyoxalase. However, his
experimental results showed that glutathione can be measured
accurately in the presence of sulfosalicylic acid. In the
course of the present work it has been observed that neutral¬
ised sulfosalicylic acid does not in any way affect the glyoxalase
system. The higher iodine consumption by the tissue filtrates
is most probably due to the interference by ascorbic acid, as
has been suggested by Woodward ( 117 ), and possibly by other
thiol compounds.
PART III
INVESTIGATIONS OH THE BLOOD AND TISSUE GLUTATHIONE CHANGES
AFTER DSHYDROASCORBIC ACID INJECTION
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PABT III
Investigations on the Blood and Tissue Glutathione Changes after
Dehydroascorbio Acid Injection?
INTRODUCTION
Almost every year, since the discovery of the diabetogenic
action of alloxan, numerous attempts to explain the mechanism
of the action of the latter substance have been published.
Leech and Bailey ( 93 ) observed a precipitous drop in the
blood glutathione of rabbits immediately after the injection
of alloxan. Since then, other observers have noted a similar
fall in the blood glutathione of rats and guinea pigs after
the injection of alloxan ( 135-137 ). Lazarow ( 133 ) claimed
that the diabetogenic action of alloxan can be prevented by a
prior injection of either glutathione or cysteine, but these
substances when injected after alloxan do not afford any
protection against its diabetogenic action. On the basis of
other experimental evidences Lazarow ( 82 ) finally postulated,
that alloxan forms an addition compound with the sulfhydryl
groups of the essential enzymes of the beta-cells in the islets
of Langerhans of the pancreas, as a result of which the enzymes
are inhibited and death of the beta-cells ensues. The protect¬
ive action of glutathione and other thiol compounds against the
toxic action of alloxan has been explained as due to the trans¬
formation of the latter to a non-diabetogenic compound by the
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former, lazarow pointed out that alloxan reacts initially
with the blood glutathione, and the concentration of the
latter in the blood falls abruptly. Since the tissues are
the secondary sites of the reaction the fall in the tissue
glutathione is not so marked. According to Lazarow, the
concentration of glutathione in the blood and in the beta
cells is of crucial importance in determining the vulnerabil¬
ity of animals to the diabetogenic action of alloxan.
It is of interest in this context to review some of the
recent publications, which lend credence to the sulfhydryl
theory of Lazarow, in relation to the production of diabetes
x?ith substances other than alloxan. Conn and his group
( 139-141 ) observed a fall in the glutathione content of
blood during the induction of diabetes in human subjects with
the adrenocorticotrophic hormone ( ACTH ), Hes3, Kyle, and
Doolan ( 142 ) confirmed the work of the aforesaid authors.
Lazarow and Berman ( 143 ) reported that cortisone injection
into rats, with the object of producing a diabetic state, is
associated with a drop in the blood glutathione j the decrease
of the latter appears to correlate with the degree of cortisone-
induced glycosuria. Nath et al. ( 144,145 ) claimed that the
subcutaneous injection of acetoacetic acid causes hyper¬
glycemia, reduction of glucose tolerance, rise in blood lactic
acid, inactivation of insulin, and a drop in blood glutathione.
The blood glutathione fall is not manifested immediately follow¬
ing the injection of acetoacetate but is observed some 90 min.
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after the injection of the diabetogenic substance. Grunert
and Phillips ( 146 ) have shown that weanling rats on a diet
deficient in sodium are more susceptible to the diabetogenic
action of alloxan than on a diet adequate in sodium. They
traced the increased susceptibility of the Na-deficient
animals to the low glutathione concentration in the blood of
these animals. Illing, Gray, and Lawrence ( 147 ), Planchart
and Villalba ( 148 ) reported that the glutathione concen¬
tration in the blood of diabetic patients is lower than that
of normal persons. Conn, Louis, and Johnston ( 149 ) investig¬
ated the role of glutathione in relation to the alleviation of
ACTH-induced diabetes in man. They found that when GSH was
injected intravenously into such persons the intensity of
hyperglycemia was temporarily reduced. However, the sulf-
hydryl theory of Lazarow ( 82 ) has not found universal support.
Joiner ( 150 ) could not confirm the work of Conn et al.
( 139-141 ). Grunert and Phillips ( 151 ), Ingbar, Otto, and
Kass ( 152 ) did not observe any change in the blood gluta¬
thione following the injection of ACTH into experimental
animals. Lazarow ( 153 ) himself observed, that the injection
of glutathione into cortisone-diabetic rats resulted in a severe
increase of glycosuria. He argues that the potentiation of the
diabetogenic action of cortisone by glutathione may be due to
the protection of the former from destruction by the latter.
Stock, Currence, and Swanson ( 154 )» Caren and Carne ( 155 )
found no abnormal value of blood glutathione in diabetic
patients.
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The close similarity of the structure and properties of
dehydroascorbie acid to those of alloxan stimulated Patterson
to search for the diabetogenic action of the former compound.
He observed that the injection of dehydroascorbic acid and
related substances into rats produced hyperglycemia and
glycosuria ( 79*80 ), but that diketogulonie acid was not
diabetogenic ( 156 )♦ Like alloxan-diabetic animals, dehydro¬
ascorbic acid-diabetic rats developed cataract ( 157,158 ) and
the diabetic symptoms v/ere ameliorated by adrenalectomy ( 159 )•
Patterson and Laaarow ( 75 ) reported that the diabetogenic
action of dehydroascorbic acid can be prevented by a prior in¬
jection of either glutathione, or cysteine. The diabetogenic
action of dehydroascorbie acid can also be prevented by previous
injection of atropine ( 160,161 ). Prom indirect experimental
evidence it has been suggested that the mechanism of the action
of alloxan and dehydroascorbic acid is similar ( 51*75 )»
The present work was undertaken to investigate the nature of
blood and tissue glutathione changes following the injection of
dehydroascorbic acid, with a view to gaining some more evidence
on the possible mechanism of the action of this substance.
EXPERIMENTAL
Before describing the actual experimental procedures, it is
felt desirable to mention the dietary history of the animals,
since diet considerably influences the production of experimental
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diabetes ( 146,162 ). Rabbits were maintained on pellets of
the following composition; Bruce and Parkes ( 163 ). Bran 15$,
Barley meal 20$, Ground-nut meal 15$, Linseed cake 10$, Dried
meat and bone meal 8$, Dried grass meal 30$, CaCO^ 1$, NaCl 1$,
The theoretical analysis of this diet is as follows; Crude
digestible protein 16,5$, Pat 4.6$, Soluble carbohydrate 33*7$,
and Piber 6.7$» Bach rabbit received approximately 100 g, of
the pellets per day, about 15 g* of hay per day and water ad
libitum, fwice a week the rabbits received additional supple¬
ments of cabbage.
Wistar albino Glaxo rats were used, fhey were maintained on
rat cubes of the following composition and water ad libitum:
Wheat offal bran 17#7$» Wheat ground 17«7$, Sussex ground oats
17«7$» Maize ground 8.8$, Meat and bone meal 8,8$, Barley
ground 8*8$, Pish meal 4»5$, Dried skimmed milk powder 14$,
NaCl 0.4$, Cod-liver oil 0.4$, Dried yeast 1.2$.
Blood was collected by cardiac puncture from rabbits and from
the abdominal aorta of rats. Heparin was used as an anti¬
coagulant. Injections were given into the marginal ear vein
of rabbits and through the tail vein of rats; before each
injection blood was drawn into the syringe to make sure that
the needle was in the vein. In a few preliminary experiments
the rabbits were sedated with nembutal but later this was
found unnecessary5 the use of nembutal does not affect the
results. Since blood samples were collected from the abdominal
aorta of rats, the animals were anesthetized by nembutal before
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laparotomy. Dehydroascorbic acid solution in 0,9$ UaCl
(100 mg,/ml,) was prepared according to Patterson ( 79 );
this solution contains traces of hydroquinone as indicated
by a positive test for the latter with Chioramine-T, The
control animals, therefore, were injected with an ether-
extracted solution of pure hydroquinone in normal saline to
simulate the conditions, with respect to hydroquinone, in
the DHA-injected animals, To prepare the above solution 0,66g,
of pure hydroquinone were dissolved in 10 ml. of ether and
shaken for 15 minutes with 10 ml, of saline. The saline
solution was removed and extracted five times with pure ether.
Finally the excess of ether was removed by suction and the
solution was used without any further treatment. It has been
observed in this work that the DHA solution prepared according
to Patterson ( 79 ) is reducible ( 95~98$ ) to ascorbic acid
by HgS at pH 3*5 and 37° ( 91 ). Unless otherwise stated,
the glutathione and total glutathione estimations in tissues
and blood were done throughout this work by the combined use
of electrolytic reduction and the glyoxalase method. Blood
and tissue filtrates were prepared with 3$ sulfosalicylic
acid as described in the last section. For the electrolytic
reduction 5 ml, of 3$ sulfosalicylic acid filtrate were reduced
for 10 minutes with a current density of 4.32 milliamperes per
sq, cm. During the course of this work blood samples were
taken at varying intervals of time after dehydroaseorbie acid
injections for glutathione analyses, and therefore, it was
expected that such blood samples would contain varying amounts
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of DEA5 since GSH donates its hydrogen to DHA ( 69 ) and it
also forms an addition compound with the latter ( 166 ), it was,
therefore, necessary to test the validity of the glyoxalase
method in the presence of varying amounts of DHA. It was ob¬
served that, when 0*125, 0.25, 0.5, and 1.0 mg, of DHA was
added to Warburg flasks containing 0'05 mg, of pure GSII, the
glyoxalase reaction remained unaffected. It should be noted
that the highest concentration of DHA used in this experiment
corresponds to the theoretical amount that would be present
in 0.5 ml. of 1:5 blood filtrate after the injection of 1 g.
of DHA per 1000 g. body weight ( assuming no loss of DHA and
the blood volume to be 100 ml, per 1000 g. of body weight ).
Blood sugar estimations were done by the method of Hagedorn
and Jensen ( 164 )» It was observed that the glucose values
in blood samples taken immediately or sometime after the In¬
jections of dehydroaseorbie acid were highs on subsequent
investigation it was found that dehydroascorbic acid solution
gives a very high blank value in this method of sugar estimation.
Blood sugar analyses, therefore, were done 24 hours after the
injection of dehydroascorbic acid.
Effect of Dehvdroascorbio Acid Injection on Blood Glutathione
Contents of Rabbits:
Eabbits/weighing between 1500-2800 g, were given an initial
desensitising dose ( D.D. ) and 15 minutes later a final dose
( 3?,D. ) of dehydroascorbio acid. She amounts of DHA that were
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injected are shovm in the Sables 11 and 12. In some animals
the final dose was not injected in one injection, hut in parts
at 10-15 minute intervals ( indicated by spaces in the tables ).
This procedure was adopted because these animals are extremely
susceptible to the injection of dehydroascorbic acid; a fact
which is a little surprising in view of the higher GSH content
of rabbit blood, as compared with rat blood. Sometimes in the
course of injections the animals showed signs of respiratory
failure, and in these the injections were discontinued, the
animals being revived by artificial respiration before the
injections were continued again. Blood from the experimental
animals v/as collected, before any injection and then at vary¬
ing intervals of time upon completion of the injection, and
analysed for glutathione and total glutathione.
In a few preliminary experiments the glutathione and total
glutathione estimations were done by the iodometric method of
Woodward and Fry ( 101 ). The data are presented in Table 11,+
It is apparent from this table that no significant fall in the
blood glutathione ( rabbitsHo, 1, 10, 24, 13 and 14 ) within
15 minutes to 1 hour after dehydroascorbic acid injection has
taken place. However, Banerjee, Belavady, and Mukherjee ( 165 )
observed a fall in the blood glutathione of rabbits, after the
dehydroascorbic acid injection, using the same method of gluta¬
thione estimation. Their observations are a little surprising
+ In Tables 11 and 12 those rabbits marked "dead" under the
column heading Treatment died within 24 hours after the
injection of dehydroascorbic acid, and their blood sugar
values were not determined.
TABLE11
ConcentrationofGlutathione(lod me ricEstimation)iR bbitBlo db f rnf r DehydroascorbicAeidInjecti n GSH-Reducedglutathione8GOxidizedglutathioneSEA-Dehydroascorbicci D.D.-DesensitizingdoseF. .-i aldo e RabbitHo. andTotal Weighting.TimeGSHG3SGGSH mg.!£mgfflg./O No.1,2100Contr.50.34.955.2 15min.46.67.353.940min.49.06.255.2 70min.42.910.453.3100min.48.47.455.8 24hrs.38.67.446.072hrs.34.36.140.4 No.10,8 0Contr.55.26.161.315mins.57.67.465.045min.57.67.465.0 75min.57.67.465.0 No.24,1500Contr.49.74.253.910mins.45.38.653.9 No.13,800Contr.42.93-746.6 15min.44.710.555.2 No.14,800Contr.46.34.050.315lain.48.46.855.2
Treatment
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in the light of the present findings and will he discussed
later. Incidentally it might be mentioned here that this
investigation was started before the publication of the above
mentioned paper. lone of the animals ( rabbits 1, 13, 14, and
20 ) which survived the dehydroascorbic acid injections
(fable 11 ) showed consistent hyperglycemia; only rabbit No. 1
showed a slight rise in the blood sugar for a few days, and
when the aehydroascorbie acid injection was repeated another
transient rise in the blood sugar was observed ( Fig, 8 ), but,
the truly diabetic type of maintained hyperglycemia was not
observed. In this animal the blood GSH was lower than could
be accounted for by expected errors of the analysis 24 and 72
hours after the injection of DEA - i.e. when there was hyper¬
glycemia. Shis may be significant, but unfortunately the
observation has not yet been repeated since none of the other
rabbits has shown comparable hyperglycemia. A somewhat similar
fall in the blood G-SH appeared in the control animals No. 6, 23
in which case, however, it was within the border limit of
experimental errors. It is interesting to note that rabbit
No. 20 which received 2 g. of 33EA for three consecutive days
shows a tremendous rise in both the reduced and total gluta¬
thione values of blood 15 minutes after the completion of the
third injection. It is rather difficult to conclude from this
experiment whether the above observation is due to a true rise
in the glutathione content of blood or is due to the interference
from ascorbic acid. Since the rabbit was injected with massive
PIG. 8. Effect of dehydroascorbic acid on the blood sugar
of rabbit No. I. The figure only shows the second
injection; the first injection ( 1.5 g. DHA ) was
given 4 days prior to the second injection.
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doses of DHA it is quite possible that the ascorbic acid level
in the blood of this animal was very high, however, as will be
evident from the results of the experiments reported below,
where glutathione estimations were done by the glyoxalase method
and the interference due to ascorbic acid was not present,
rabbits when injected repeatedly with BEIA showed a similar
rise in the blood glutathione values. Sable 11 shows that the
GSSG- values in the blood of the dehydroascorbic acid injected
animals tend to rise. The rise in the G-SSG values of blood
is not characteristic of the MA-injeeted animals; the
hydroquinone-injected animal and saline-injected animal also
show a similar trend.
Since the method for the estimation of glutathione lacked
specificity in the foregoing experiments, it was decided to
repeat those experiments estimating the reduced and total
glutathione in the blood by the specific manometric method.
The results of such experiments are presented in Table 12.
It is clear from this table that there is no significant fall
in the blood glutathione ( rabbits ho, 25, 26, 27, 28, 29, 38,
44 ) immediately following the injections of massive doses of
DHA. On the contrary, rabbit ho. 29 which received repeated
injections of DHA shows, like Eabbit ho. 20 of Table 11, a
tremendous rise in the glutathione and total glutathione values
of blood. In this animal the blood glutathione analyses were
done on the first day before any injection and after the final
dose at different intervals of time; again on the third day
TABLE12



































































































































mg.?i> 48.2 46.0 54.0 47.5
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40 38 43 38
No.50,16 0 .51,1800
mg.f»
Contr.35.09days after firstinj.34.3 Contr.43.19days after firstinj.34 3
13.2 11.7 10.9 13.2
Beoeived0.6g.f DHA/Kg.in4equal dosesinourHour after12hrs.f sting Samesabove
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before and after tlie third injection as indicated in the
table, The w 0 " time in Table 12 signifies that the blood
sample was drawn while the last portion of the 3HA was in¬
jected; this technique is similar to that of leech and
Bailey ( 93 ) when they studied the effects of alloxan on
blood glutathione. No significant change in blood sugar was
observed in the surviving animals (rabbitsNo. 38, 44 )•
Patterson ( 79 ) originally reported that rats could be made
diabetic with a single injection of 1.1 g. of DHA per Kg. body
weight. Patterson and lazarow ( 75 ) made rats diabetic by
injecting 0.7 g, of BHA per Kg. of body weight for 3 consecut¬
ive days. Tables 11 and 12 show that the mortality rate in
rabbits is very high when dehydroascorbic acid is injected
around dose level of 1,1 g#/Kg. It has been found in the
course of this work that, it is almost impossible to inject
0,7 g. of DHA per Kg. into rabbits for 3 consecutive days;
out of the 10 rabbits tried only two survived - No. 20
( Table 11 ) and Ho. 29 ( Table 12 ). Unfortunately, the
latter rabbit died within an hour after the 3rd injection on
the third day, therefore, its blood sugar changes could not be
followed, and as has been stated elsewhere in the former rabbit
no significant change in the blood sugar was observed. It was
decided, therefore, to inject BHA repeatedly into rabbits in
small doses for longer periods of time. Rabbits No. 33, and
34 ( Table 12 ) were injected for six consecutive days with
500 mg. of DHA. Twenty-four hours after the completion of the
—66—
injections "blood samples were taken for glutathione and sugar
analyses. It can he seen from Table 12 that the hematocrit
value in the blood of rabbit Ho. 33 has decreased, but the
reduced and total glutathione values have increased; in
rabbit Ho. 34 the hematocrit value has decreased by 5$ but
the reduced and total glutathione values remain unchanged.
These findings indicate that the glutathione and total gluta¬
thione contents have increased in the red cells. Hone of these
rabbits was hyperglycemic for five days after the injections.
Leech and Bailey ( 93 ) reported the same type of increase
in the blood glutathione after repeated alloxan injections in
small doses. This increased glutathione production in the
body is quite conceivably an attempt of the latter to increase
its resistance against such toxic substances as alloxan and
dehydroascorbic acid.
Princiotto ( 81 ) reported that rabbits when starved for 12-24
hours could be made diabetie by injecting 0.6 g./Kg. of PEA in
four equal doses at 15 minute intervals. In this work the same
procedure was tried on rabbitsHo. 50 and 51 ( Table 12 ). These
animals were starved for 12 hours and then injected with the
aforesaid amount of DHA at the specified time intervals. Blood
sugar analyses were done for four days after the injections and
varied between 84-110 ag.$. On the fifth day, after 24 hours
fasting, the same rabbits were injected again with the same
dose of DHA in the same way. Blood sugar analyses were done
for the next four days and showed no change. Blood glutathione
analyses were done after 12 hours fasting just before the first
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injection of DHA and again on the 9th day after 12 hours fast¬
ing* Reference to Table 12 shows that the hematocrit values
as well as the glutathione and total glutathione contents of
the blood have decreased in these animals* In these cases,
however, the increase in the glutathione and total glutathione
values of "blood as observed in rabbitsHo. 29, 33 and 34 is not
present. She most plausible explanation is that the injections
of DHA were given too far apart.
Reduction of Dehydroascorbic Acid b.v Rabbit Blood:
Several investigators have suggested that glutathione is respon¬
sible for the reduction of DHA ( 7,21,69,74 ). Since the preced¬
ing experiments did not show any significant change in the blood
glutathione after dehydroascorbic acid injection, it was, there¬
fore, decided to investigate whether DHA is appreciably reduced
to ascorbic acid in the rabbit blood.
The following experimental procedure was adopted; In Vivo;
Rabbits weighing between 2100-2900 g. were injected with 1000-
1500 mg. of DHA in divided doses within 30 minutes. Blood
samples were collected before and 15 minutes after the com¬
pletion of the injections and analyzed for ascorbic acid and
total ascorbic acid. Immediately upon collection the blood
samples were saturated with carbon monoxide ( to prevent oxidat¬
ion of ascorbic acid by hemoglobin during deproteinization ) and
then centrifuged. Ascorbic acid and total ascorbic acid estimat¬
ions were done in the plasma and red cells by the indophenol ( 83 )
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and phenylhydrasine ( 87 ) methods. The latter method does not
differentiate "between dehydroascorbic acid ( DHA ) and diketo-
gulonic acid ( DKA ), hence EgS reduction was applied to the
metaphosphoric acid filtrate, as described by levenson et al,
(91 )» to differentiate between the two substances. In Part
I of this thesis it has been stated that because of the lack
of specificity of HgS reduction it cannot be applied to
differentiate between DHA and DKA when these substances are
present in small amounts ( 0,07-0,3 mg»$ ) in biological
materials. In this experiment, however, the concentrations of
DHA in the red cells and plasma, after EfflA injection, were very
high ( vide infra ). At such high levels of DHA the figures
obtained after HgS reduction of the latter, by the indophenol
method are reasonably accurate; the interfering substances
constitute only a fraction of the amount estimated. In Vitro:
Ascorbic acid or dehydroascorbic acid solutions in 0,9$ HaCl
were added to whole blood ( saturated with CO ) and incubated
for 1 hour at 37°. At the end of incubation period the blood
was centrifuged and ascorbic acid determinations were done in
the red cells and plasma by the indophenol method ( 83 ),
Table 13 shows that when DHA is injected into rabbits the
ascorbic concentration in the red cells greatly increases.
The results of the in vitro experiment in Table 14 show that
the levels of the ascorbic acid in the red cells of rabbits
rise to a significant extent when the red cells are incubated
with DHA. Both the results of the in vivo and in vitro
TABLE13























































Concentrations of Ascorbic Acid in Plasma and Red Blood Cells
before and after Addition of Dehydroaseorbic Acid or
Ascorbic Acid to Whole Blood
AsA — Ascorbic acid DHA - Dehydroaseorbic acid
Species Concentration Material analyzed Ascorbic acid
and form of found
substance added
mg. per cent mg. per cent
Rabbit 25 DBA Control plasma 0,9
Plasma after 2.4
incubation
Control red cells 0,5
Red cells after 1.5
incubation
Rabbit 24*3 AsA Control plasma 0.48
Plasma after 23.8
incubation
Control red cells 0.35
Red cells after 0.38
incubation
Rabbit 24.3 AsA Control plasma 0.48
Plasma after 23»1
incubation
Control red cells 0.35
Red cells after 0.38
incubation
experiments strongly suggest that DHA is reduced to AsA in
the red cells# The results of the in vitro experiments in
Table 14 show that ascorbic acid does not enter into the red
cells of rabbits* Other observers ( 21,167 ) have also report¬
ed that both in vivo and in vitro the erythrocytes of human,
cat, dog, rat, sheep, pig,and bovine are impermeable to A3A*
Hence the increase in the ascorbic acid content of the red
cells as observed in the in vivo and in vitro experiments
above is not due to the entry of ascorbic acid into the red
cells.
It is clear from the results of the above experiments and those
in the last section that, in vivo DHA is reduced to a consider¬
able degree in the red cells of rabbits and concurrent with the
reduction of the DHA no significant change in the blood gluta¬
thione takes place# There is a possibility that the GSH is
regenerated from the GSSG very rapidly by the glutathione
reductase in blood ( 68 ); i.e. the second of the following
reactions is very effective:
(1) DHA + 2GSH s AsA + GSSG
(2) GSSG + TPim2 * 2GSH + TPH
However, Ball and lehninger ( 68 ) have also shown that the
specific activity of the glutathione reductase in the rat
liver is higher than in the blood. Since in the course of
this work a fall in the liver glutathione of rats after DHA
injections under similar experimental conditions has been
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observed ( vide infra ), the above possibility may be ruled out.
It can be concluded, therefore, that glutathione is not
responsible for the reduction of dehydroascorbic acid in the
rabbit blood.
The data in fable 13 also show that the AsA concentration in the
plasma rises after DHA injection. The results in fable 14 show
that the ascorbic acid concentration in the plasma increases
after incubation of whole blood with DHA. fhe rise in the
plasma ascorbic acid may be due to the reduction of DHA in the
plasma or to the passage of AsA from the red cells and other
cells in the body. Experiments have not been done to verify
whether rabbit plasma reduces DHA to AsA; because the main
object of this experiment was to observe.whether glutathione
is responsible for the reduction of DHA and plasma does not
contain any glutathione. If DHA is reduced in the plasma the
reducing agent is certainly not glutathione.
It is easily discernible from fable 13 that after the DHA in¬
jections the total ascorbic acid values in the plasma and red
cells are higher than the corresponding ascorbic acid values,
fhis indicates that the whole of the injected DHA has not been
reduced to AsA but is present either as DHA or DKA. Since the
total ascorbic acid value,after the DHA injections,in the plasma
and red cells as obtained by the phenylhydrazine method are
higher than those obtained by the indophenol method after HgS
reduction, it indicates that a considerable amount of the
Injected DHA has been converted to DKA. The degree of con¬
version of the injected DHA to BKA is far greater in plasma
than in red cells.
Effect of Dehydroasoorbic Acid Injection on Blood and Tissue
Glutathione Contents of Rats:
Since diabetes could not "be produced in rabbits with dehydro-
ascorbic acid, it was of interest to know whether rats could
be made diabetic with the latter substance as has been claimed
by Patterson ( 79#80 ),
The following experimental procedure was adopted; Rats^weigh-
ing between 145-160 g. were divided into two groups in such a
GUd /at*.
way that the distribution of the body weight/remained approxi¬
mately the same in both groups. One group was kept as control
and the rats in the other group were injected with DHA
( experimental ). The experimental animals were injected
with 0.7-0.8 ml. of dehydroascorbic acid solution ( 100 mg./ml.)
per 100 g. body weight for three consecutive days. Before the
first injection the rats were desensitized with 0.3 ml. of the
above dehydroascorbic acid solution per 100 g. body weight.
The control animals were injected with 0.7-0.8 ml. of ether-
extracted hydroquinone solution per 100 g. body weight. Both
the control and the experimental animals were starved for 12
hours before the first injection. Because of experimental
limitations# the control and experimental animals were not
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injected at the same timej the experimental animals were in¬
jected first. Prom 4-10 days after the last injection, the
experimental animals were sacrificed a few at a time. The
animals were anesthetized with nembutal and laparotomized;
blood was collected from the abdominal aorta for glutathione
and sugar analyses. Glutathione analyses were also performed
in the liver and pancreas. The same experimental procedure
was followed for the control animals after hydroquinone in¬
jection. The blood, liver, and pancreas were analyzed for
glutathione. The tissues ( pancreas, liver, kidney, thyroid,
and suprarenal ) were.taken from control and experimental
animals for histological examination.
Table 15 shows that 100$ of the rats became hyperglycemic
after the injections of dehydroascorbic acid, nevertheless,
the glutathione contents of the blood, liver, and pancreas
of the control animals axe not significantly different from
those of the diabetic animals. The total and oxidized gluta¬
thione concentrations in the blood of experimental animals
are almost similar to those of the control animals. It is
interesting to note that the total glutathione values are
not consistently higher than the glutathione values in the
liver and pancreas of both diabetic and normal rats. This
indicates that the oxidized glutathione is not present in
the tissues of control animals and it does not appear in the
tissues of diabetic rats. It is concluded, therefore, that
in established dehydroascorbic acid-diabetic rats the gluta¬
thione concentrations in the blood, liver, and pancreas
TABLE 15
Glutathione Contents of Blood and Tissues of Control and DHA-Diabetic Rats
GSH - Reduced glutathione GSSG - Oxidized glutathione DHA - Dehydroascorbic acid
Control rats
Blood Liver Pancreas
Rat Control After GSH GSSG Total Rat Control After GSH GSSG Total Rat Control After GSH GSSG Total
No. sugar inj. GSH No. blood inj. GSH No. blood inj. • GSH
sugar sugar blood sugar blood
sugar sugar
mg.$ mg.^ mg.$ mg.$ mg.^ mg.% mg.$ mg .% mg.$ mg.$ mg./£ mg.$ mg.$
11 102 102 18.2 25.6 43.8 1 108 89 135.5 mm 3 105 48,3 47.1
12 98 - 17.5 24.4 41.9 2 - 147 193.1 0 193.1 4 105 - 55.8 - 51.4
13 - - 20.7 23.1 43.8 3 105 - 231.7 - • 7 99 - 57.5 - 47.2
14 - - 22.5 22.5 45.0 4 105 - 241.5 - - 8 107 140 62.5 - -
15 - - 24.4 23.8 48.2 5 99 96 147.6 - -
16 114 - 20.0 18.2 38.2 6 107 124 229.5 «. 228.3
17 98 - 18.0 19.5 37.5 7 99 - 225.2 CO
18 114 - 15.0 21.3 36.3 8 107 140 200.7 - -
19 105 - 18.8 25.6 44.4 9 108 138 174.8 7.0 181.8
20 105 - 17.5 20.5 38.0 10 107 124 199.4 - -
Mean GSH 19.2 ± 2 .72 Mean GSH 197 .9 ± 36 .1 Mean GSH 56.0 ± 5.9
TABLE 15 ( Contd.)
LHA-diabetic rats
Blood Liver Pancreas
Rat Control After GSH GSSG Total Rat Control After GSH GSSG Total Rat Control After GSH GSSG Total
No, sugar inj. GSH No. blood
, inj. GSH No. blood inj. GSH
sugar sugar blood sugar blood
sugar sugar
mg.% mg.% rag.% mg.% jng./S ng.% Blg.% mg.% mg.% #. • • rag.% xng.# iag.% xng.%
17 333 21.3 24.4 45.7 3 126 378 179.6 0 179.6 4 112 416 73.5 • 58.8
18 - 336 18.8 16.2 35,0 4 112 416 214.7 0 214.7 8 101 423 85.2 • 60.2
19 - 461 26.2 15.8 42.0 6 126 392 164.6 1.2 165.q 9 124 392 52.7 0 52.7
23 «• 436 23.8 15.2 39.0 7 118 423 218.0 208.3 12 99 349 48.5 0 48.5
27 mt 500 23.2 16.8 40,0 8 101 423 237.3 34.4 271.7
28 - 235 18.2 20.0 38.2 9 124 392 188.3 1.9 190.2
13 94 428 204.5 «. -
16 120 427 241.5 - -
Mean GSH 21.9 ± 3.08 Mean GSH 206.0 t 27.2 Mean GSH 64.9 t 17.4
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remain practically unaltered.
At this stage, it was decided to estimate the glutathione
contents of the "blood, liver, and pancreas of rats immediately
after DHA injections. In vivo/the half life of DHA is only a
few minutes ( 23*168,169 ) and therefore, it was expected that
any change in the glutathione contents of the blood and tissues
would "be manifested within a short time after the DHA injection.
The experimental and technical procedure used was as follows:
Hats/weighing "between 130-160 g, were injected with 0.7 ml. of
dehydroascorbic acid solution ( 100 mg./ml.) per 100 g. "body
weight for two consecutive days. (The desensitising dose was
the same as in the previous experiment. On the third day, the
rats were anesthetized xirith nembutal and injected with the
aforesaid amount of DHA. She animals were laparotomized and
at 10, 15 and 17 minutes after the DHA injection blood, liver
and pancreas were collected respectively for glutathione
analyses. Blood samples were taken before the third injection
for sugar analyses.
The same experimental procedure was repeated on a control
group of rats of similar body weight which were injected with
ether-extracted hydroquinone solution instead of DHA.
It is clear from Table 16 that the glutathione and total
glutathione concentrations in the blood of the control animals
are not significantly different from those of the experimental
animals. The glutathione concentrations in the liver of the
GSH -
TABLE 16
Glutathione Contents of Blood and Tissues of Control and CHA-Injected Hats







Rat Sugar GSH GSSG Total! Rat Blood GSH GSSG Total ! Rat Blood GSH GSSG Total
Ho. before GSH ! Ho. sugar GSH No. sugar GSH
3rd inj. ii before ii before
i
i
3rd inj • ii 3rd inj.
ag«£ rag.% «, n r-lag./© rag.% | Ei£.$ i mg.jo EJg.%
1 124 16.3 23.7 40.0 j 1 124 221.0 0 221.0 ! 1 124 53.8 mm .
3 108 16.3 19.9 36.2 J 2 114 219.8 . 2 114 63.4 - -
4 101 16.3 21.2 37.5 i 3 108 204 .8 - 3 108 60.1 mm
5 117 15.0 21.2 56.2 ! 4 101 241.0 0 241.0 ! 4 101 62.1 w» tea
6 113 16.5 19.1 35.6 | 5 117 201.9 - • j 5 117 59.7 - -
7 - 18.8 19.9 38.7 | 6 113 208.8 - 6 113 54.3 - -










Mean GSH 58.9 ± 3.99
TABLE 16 ( Contd.)
DHA-Injected rats
Blood Liver Pancreas
Rat Sugar GSH GSSG Total Rat Blood GSH GSSG Total Rat Blood GSH GSSG Total
No. "before GSH Ho. sugar GSH NO. sugar GSH
3rd inj * before before
3rd inj • 3rd inj.
mg.ft mg.& mg.$ mg.^ mg.Jfe mg.$ mg.% mg.^ xng.$
1 402 18.5 23.5 42.0 1 402 231.0 CM 215.1 1 402 96.6 -
7 363 16.9 21.2 38.1 2 - 147.9 4.4 152.3 2 - 52.6 -
8 214 18.8 17.4 36.2 7 363 132 .2 - 120.4 7 363 102.5 MM
9 328 14.0 17 .2 31.2 8 214 137.6 0.4 138.0 8 214 69.5 -
10 230 16.3 19.3 35.6 9 328 118.7 - - 9 328 68.1 -
11 122 18.5 19.0 37.5 10 230 167.5 - 10 230 61.2 -
11 122 72.8
Me%n GSH 17.1 ± 1 .74 Mean GSH 155.8 i 40,,29 Mean GSH 74 .7 ± 18.25"
mJf&rn,
EHA-injeeted animals are lower than those of the control
animals. This difference is significant ( P < 0.01 ). It
is interesting to note that the glutathione contents of the
pancreas of the experimental animals are higher than those
of the control animals* This difference is most probably due
to the variation in the water content, because, the whole
pancreas of a IDHA-injeeted animal weighs less than that of
a control animal. The significance of these results will be
discussed later.
Effect of pehydroascorblc Acid Injection on liver Glutathione
Contents of Eats:
The above experiment has shown that the glutathione content
of the liver falls after 33HA injection. This observation has
been further verified by experiments of different nature .
The technique was as follows; A rat was laparotomized under
nembutal anesthesia and a suitable amount of liver tissue was
taken out for glutathione analysis. The bleeding was con¬
trolled by mosquito hemostats and pads of cotton wool. Then
the rat was given a priming dose of2o-2$mg» of DHA per 100 g.
body weight; 15 minutes later another dose of 6o~1£j-o mg, of
UHA per 100 g. body weight was injected. Another sample of
liver tissue was taken out for glutathione analysis 15 minutes
after the last injection. The same experiment was repeated on
rats injected with normal saline.
-75-
Similar experiments were done in vitro. The experimental and
technical procedure used was as follows: -The whole liver
of a rat was extracted with phosphate buffer at pH 7.4. The
tissue debris was not separated. To the extract DHA was added
to make a concentration of 20 mg. of DHA per 100 ml* in the
extract. The sample was incubated for 30 minutes at 37°.
Samples of the extract were taken out for glutathione analyses
before and after incubation with dehydroascorbic acid.
B. The whole liver of a rat was extracted with phosphate
buffer at pH 7*4? the extract was centrifuged and filtered.
A sample of the filtrate was taken out for glutathione analysis.
The rest of the filtrate was divided into two equal parts;
one half was used as control and to the other half DHA was
added to give a concentration of 100 mg. of DHA per 100 ml. in
the filtrate. Immediately upon addition of DHA a portion of
the filtrate was taken out for glutathione analysis. Both the
control and the sample to which HEIA had been added were incubat¬
ed for an hour at 37°. Aliquots of the samples were taken out
after 30 minutes and at the end of the incubation period for
glutathione analyses.
The results of these in vivo and in vitro experiments are shown
graphically in Big. 9* The top half of the figure shows the
results of the in vivo experiments and the lower half those of
the in vitro experiments. To facilitate presentation, the
concentrations of glutathione in the liver extracts are expressed
in mg. of G-SH per 100 g. of liver.
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It is easily discernible from Pig. 9 that the glutathione
concentration in the liver of "both the ISA-injected animals
( DHA^ and BHAp ) has fallen to a significant extent. On the
other hand, the saline-injected animals ( Saline-; and Salinep ),
under the same experimental conditions, do not show any change
in the liver glutathione concentration. It should "be pointed
out in this context that the choice of saline instead of ether-
extracted hydroquinone solution for injection into the control
animals was purely arbitrary. It has "been observed In the
course of this investigation that hydroquinone does not cause
any change in the glutathione contents of liver or blood.
Curve A in the above figure shows the result of 30 minutes
incubation of liver brei with BHA ( 20 mg. of DHA per 100 ml.
extract ). A definite fall in the glutathione concentration
of the liver extract Is clearly shown.
Curve Bp in Pig. 9 shows the effect of incubation, of liver
filtrate ( without cell debris ) with DEHA ( 100 mg. of BHA
per 100 ml. filtrate ), on the glutathione concentration of
the liver filtrate, She parallel control of the same filtrate
( without DHA ) is represented by curve It can be observed
( curve B0 ) that within 3 minutes of the addition of BHA the
concentration of GSH in the filtrate has started falling and
after 30 minutes of incubation the G-SH content is reduced to
aero value. On the other hand, some loss of GSH occurs in the
control filtrate ( curve B1 ) within 30 minutes but after that
FIG. 9. IK VIVO: Glutathione concentration in rat liver before
and 30 min. after DHA or saline injection. DHAy, 3° iag.
of DHA injected per 100 g. body wt.j DHA2> 164 iag. of
DHA injected per 100 g. body wt; SalineT and Saline?,
^ ml, of 0.9# NaCl injected.
IN VTfRO: Glutathione concentration in liver extracts
( liver extracted with phosphate buffer at pH 7.4 ) of
rats before and after incubation at 37° with or without
DHA. A, DHA was added to the extract to give a concen¬
tration of 20 mg.#; Bi and B2 are the two halves of the
same extract; to Bj no DHA was added and to B2 DHA was
added to give a concentration of 100 mg.#.
the loss of G-SH is very snail. She fall in the GSH content
of the control filtrate may he expected, because glutathione
is very unstable at pH 7.4. However, the difference between
the control sample and the sample to which DHA was added is
quite marked. The changes in the ascorbic acid values of the
sample to which BHA had been added ( curve Bg ) are shown
below.
Concentration of ascorbic acid before the addition of DHA
17.6 mg./lOO g. of liver.
Concentration of ascorbic acid after 30 min. incubation with
DHA 130.6 mg. per 100 g, of liver.
Concentration of ascorbic acid after 60 minutes incubation
with DHA —— 152.0 rag, per 100 g, of liver.
The results of this experiment and those of the previous section
strongly suggest that glutathione is responsible for the reduct¬
ion of dehydroascorbic acid in the liver.
Effect of Alloxan In.ieetion on Blood Glutathione of Rabbits:
Leech and Bailey ( 93 ) originally reported that immediately
after alloxan injection a sharp drop in the glutathione con¬
centration of blood occurs. They, however, did not use a
specific method for the estimation of glutathione. It was,
therefore, of interest to repeat the work of the above authors
and to observe whether similar changes can be demonstrated by
the specific glyoxalase method.
The following experimental procedure was adopted: Babbits(<?" 9)
weighing between 1500-3000 g» were injected intravenously with
200 mg./Kg. body weight of alloxan. Blood samples were collect¬
ed at various intervals of time for glutathione analyses by the
glyoxalase method as well as by the method of Benedict and
Gottscliall ( 114 ) as modified by Potter and Frahke ( 115 )•
The latter method was used by leech and Bailey and it measures
only GSH.
It is easily discernible from Table 17 that a precipitous fall
in the blood glutathione immediately after alloxan injection
can be demonstrated by both the methods. The glutathione values
obtained by the method of Benedict and Gottschall are higher
than those obtained by the manometrie method. This is quite
conceivable, because, the former method is not specific for
glutathione. The total glutathione values obtained by the
glyoxalase method immediately after alloxan injection are lower
than before alloxan injection. This indicates that the reduced
glutathione has not been simply oxidized by the alloxan, but
the latter substance has formed, probably, an addition com¬
pound with glutathione as has been suggested by lasarow and
his coworkers ( 170,171 ). Dr. Eobson, working in this
laboratory, has confirmed the above finding.
TABLE 17
Concentration of Glutathione in Rabbit Blood before
and after Alloxan Injection
GSH —• Reduced glutathione GSSG — Oxidized glutathione
Rabbit No, Time Hemato- Glyoxalaee Benedict and
and crit method Gottschall's
Weight in g. Total method
GSH GSSG GSH GSH
























































































Soon after the discovery by Patterson ( 79,80 ) that dehydro-
ascorbic acid is diabetogenic in rats, Princiotto ( 81 ) claim¬
ed that rabbits could be made diabetic with the same substance.
In a recent communication, however, Banerjee et al# ( 165 )
reported that they could not produce diabetes in rabbits with
dehydroascorbic acid. It may be pointed out in this context
that, the experimental technique of Banerjee et al, is a little
different from that of Princiotto. Banerjee et al. injected
dehydroascorbic acid intravenously into non-fasting rabbits at
a dose level of 1 g./Kg, or 1.5 g»/Kg, in two injections at 10
minute intervals; a dose which is diabetogenic in rats ( 79 ).
On the other hand, Princiotto starved the rabbits for 12-24
hours and then injected intravenously 0,6 g./Kg. of dehydro¬
ascorbic acid in four equal doses at intervals of 15 minutes.
In the present work, dehydroascorbic acid was injected intra¬
venously into rabbits at varying dose levels using different
techniques including that used by Princiotto, In no instance,
however, rabbits could be made diabetic with dehydroascorbic acid.
Heither Patterson nor Lazarow has injected dehydroascorbic acid
into rabbits (personal communication). She results of the pres¬
ent work and those of Banerjee et al. make it unlikely that
dehydroascorbic acid is diabetogenic in rabbits.
In the course of the present investigation, attempts were made
initially to measure the blood glutathione of rabbits, after
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dehydroascorbic acid injections, using the iodometric method
of Woodward and Fry ( 101 ). Ho significant change in the blood
glutathione was observed# Later, however, the above method of
glutathione estimation was discarded in view of the fact that
the ascorbic acid level in the blood increases greatly after
dehydroascorbic acid injections and ascorbic acid at high con¬
centration interferes with the iodometric method giving falsely
high glutathione value. In view of this, it is surprising that
Banerjee et al# ( 165 ) using the same method of glutathione
estimation ( 101 ) could observe a fall in the blood glutathione
of rabbits after dehydroascorbic acid injections. Furthermore,
Oft vifsco (j>H */-3-7-lf.)
the half life of deiiydroascorbic acid in vivo/is only a few
minutes ( 25,168,169 ); if glutathione is responsible for the
reduction of deiiydroascorbic acid, then any change in the blood
glutathione should be apparent a few minutes after the injection
of dehydroascorbic acid. The observation of Banerjee et al. is
inconsistent with this idea since they reported the fall in the
blood glutathione 1-24 hours after the injection of dehydroascorbic
acid. The present author, however, using the specific glyoxalase
method for the estimation of glutathione, did not observe any
significant change in the blood glutathione of rabbits during the
first hour after dehydroascorbic acid injections. On the other
hand, when dehydroascorbic acid was injected repeatedly into
rabbits, a rise in the blood glutathione was observed. A similar
rise in the blood glutathione of rabbits after repeated injections
of alloxan in small doses has been observed by Leech and Bailey
-81-
( 93 ). The significance of this change has "been discussed
elsewhere.
It is well established that, in vivo and in vitro dehydroascorbic
acid is reduced to ascorbic acid in the blood —~— -
- ^ and tissues ( 18-24,73,74,173-176 ). In the present work
an increase in the ascorbic acid concentration of rabbit erythro¬
cytes, has been observed both after the injection of dehydroascorbic
acid and after incubation of T/hole blood with dehydroascorbic acid.
The possibility that the increase in the ascorbic acid concentrat¬
ion of the erythrocytes is due to the entry of ascorbic acid into
the red blood cells has been excluded by in vitro experiments.
Since no significant change in the blood glutathione has been ob¬
served after dehydroascorbic acid injections into rabbits, it has
been concluded that glutathione is not responsible for the reduct¬
ion of dehydroascorbic acid in the rabbit blood.
The results also indicate that when large doses of dehydroascorbic
acid are injected into rabbits, a considerable portion of this sub¬
stance undergoes an irreversible transformation into diketogulonio
acid.
In contrast to rabbits, rats were easily and regularly made diabetic
with deh^ddroascorbic acid. This confirms the work of Patterson
( 79,30 ) and Patterson and Laaarow ( 75 ). Histological studies
( see appendix ) indicated that dehydroascorbie acid-induced
diabetes is pancreatic in origin. The glutathione values in the
blood, liver, and pancreas of the permanently diabetic animals
-82-*
were not significantly different from those of the control
animals. This is quite consistent with the fact that the turn¬
over of glutathione is very rapid "both in vitro and in vivo
( 52-55 )» so that the changes in the glutathione concentration
of "blood or tissue which might occur immediately after dehydro-
ascorbie acid injections \70uld not be manifested in the perman¬
ently diabetic condition#
However, no significant change in the blood glutathione could be
observed in rats immediately after dehydroascorbic acid inject¬
ions; on the other hand, in common with other workers it has
been observed that alloxan causes a precipitous fall in the blood
glutathione of rabbits. This raises the question whether the
fall in the "blood glutathione is of any significance in the pro¬
duction of experimental diabetes, A survey of the literature
shows that ninhydrin, a non-diabetogenic substance, also causes
a fall in the blood glutathione which is similar to that induced
by alloxan ( 135 )• Furthermore, a fall in the blood glutathione
of guinea pigs immediately after alloxan injection has been demon¬
strated ( 136,137 ), although these animals are resistant to the
diabetogenic action of alloxan ( 136,137,177 ). Judging from
these facts it can be concluded that a fall in the blood gluta¬
thione is not specificaliy related to the production of experi¬
mental diabetes.
In the present work a consistent fall in the liver glutathione of
rats immediately after dehydroascorbic acid injections has been
observed; a fall in the glutathione content of liver extracts
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has also been shown to. occur on incubation with dehydroascorbic
acid. This is probably due to the reduction of dehydroascorbic
acid in the liver by glutathione. It is of interest to note
that Bruckmann and Wertheimer ( 135 ) did not observe any change
in the liver glutathione of rats immediately after alloxan
injection; Brada ( 178 ), on the other hand, observed a fall
in the liver glutathione of rats after alloxan injection,
nevertheless, the significance of the fall in the liver gluta¬
thione following alloxan or dehydroascorbie acid injection in
relation to the production of experimental diabetes is obscure.
Immediately following the injection of dehydroascorbic acid the
glutathione contents of the pancreas of rats were not significant¬
ly different from those of the control animals. The data in the
literature on the glutathione content of the pancreas following
the injection of alloxan are subject to considerable controversy.
Bruckmann and Wertheinter ( 135 ) could not observe any significant
change in the glutathione content of the pancreas of rats follow¬
ing the injection of diabetogenic dose of alloxan. Brada, ( 178 ),
however, found a significant fall in the glutathione concentration
of the pancreas of rats after alloxan injection. The present
author believes, in common with Bazarow ( 82 ), that very little
information regarding the concentration of glutathione in the
beta-cells of the islets of Bangerhans of the pancreas can be
gained from the results of glutathione analyses of the whole
pancreas, because the beta-cells constitute only a fraction (0.5$)
of the total weight of the organ. Unfortunately, however, at the
-84-
present time there is no method available for the quantitative
separation of the beta-cells from the acinar tissues of the




G5NSRAL CONCLUSIONS AND SUGARY
1. The ascorbic acid and total ascorbic acid contents of the
plasma of rabbits have been estimated under different experimental
conditions. The limitations of the various methods used for the
accurate estimation of dehydroascorbic acid ( DKA ) have been
discussed. The results suggest that appreciable quantities of DHA
do not exist in the plasma of normal or of alloxan-diabetic rabbits.
2. The reduced glutathione ( GSH ) content of blood can be
estimated equally well by the iodometric and glyoxalase methods.
Only the latter method is reliable for the estimation of GSH in
tissues. By comparative study it has been shown that the iodo¬
metric method is unreliable for the accurate estimation of total
glutathione in blood. Certain modifications have been suggested
for the accurate estimation of total glutathione ( reduced plus
oxidized ) in blood by the combined use of electrolytic reduction
and the glyoxalase method. It has been demonstrated by the
modified technique that considerable amounts of oxidized gluta¬
thione ( GSSG ) are present in the blood of humans, rabbits, and
rats. Unlike blood, tissues do not contain any measurable quantity
of GSSG.
3. DHA is reduced to a significant extent in the red blood cells
of rabbits both in vitro and in vivo. Since no significant change
in blood GSH takes place concurrent with the reduction of DHA it
is concluded that GSH is not responsible for the reduction of DHA
in rabbit blood. VVhen DHA is injected intravenously into rabbits
to give very high blood concentrations, a considerable portion of
-86
tli© BHA in plasma and in red blood cells appears to undergo an
irreversible change to diketogulonic acid.
4. It has not been possible to produce diabetes in rabbits by
the intravenous injection of BHA, whereas rats have been found to
be easily and regularly susceptible to the diabetogenic action of
BEA, The GSH contents of blood, liver, and pancreas of rats made
diabetic with BHA are not significantly different from those of
the control animals. GSSG does not appear in the tissues of
diabetic rats nor does the amount of this substance in the blood
of diabetic rats increase.
5. The G-SH concentration in blood of rabbits and rats does not
alter immediately after intravenous injection of BHA. In contrast
to this a precipitous, but temporary, fall in blood GSH of rabbits
after alloxan injection has been observed. The significance of
this fall in blood G3K has been discussed and it has been con¬
cluded that the fall in blood GSH is not specifically related to
the production of experimental diabetes.
6. The GSH content of rat liver falls immediately after BHA
injection but that of the pancreas remains unaltered. It has
been observed also that GSH content of rat liver extracts falls
after incubation of the latter with BHA and it has been concluded
that GSH is responsible for the reduction of BHA in the liver.
The significance of the changes in GSH concentrations of tissues
after injections of diabetogenic substances has been discussed.
-87-
APPENDIX
Histological Examination of the Tissues of Dehvdroascorbic
Acid-Diabetic Rats:
The liver, Icidney, suprarenal, and thyroid of the diabetic rats
showed no significant histological changes. The islets of
langerhans in the pancreas of the diabetic rats, however,
showed signs of degenerative changes* Prom Pig. 11 the
following degenerative changes can be easily seen;
a) disruption of the normal structure of the islet,
b) vacuolation or loss of cytoplasm of the islet cells,
c) pyknosis and variation in size and shape of the nuclei.
In the actual stained section, however, some further changes
were observed; viz* the degenerative cells are almost all
beta-cells, the alpha-cells being relatively unaffected;
there is loss of normal peripheral arrangement of the alpha-
cells; lymphocytic infiltration is present in the islets.
FIG. 10. An islet of Langerhans in the pancreas of a
hydroquinone injected rat ( control ) X 550
FIG. 11. An islet of Langerhans in the pancreas of a
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